
        <html>
        <head>
            <style>
                body { font-family: Arial, sans-serif; line-height: 1.6; margin: 20px; }
                h3 { color: #333; }
                .question { margin-bottom: 15px; }
                .options { margin-left: 20px; margin-bottom: 10px; }
                .solution { background: #f8f9fa; padding: 10px; border-left: 4px solid #007bff; }
                .credits { text-align: center; margin-top: 20px; font-size: 18px; }
                .rainbow-text { 
                    background: linear-gradient(90deg, red, orange, yellow, green, blue, indigo, violet); 
                    -webkit-background-clip: text; 
                    color: transparent; 
                    font-weight: bold; 
                }
            </style>
        </head>
        <body>
        
            <div class="question">
                <h3>Question No: 1</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following color code is not included in friage?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Black</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Blue</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Green</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Red</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>There are four color code (Red-Immediate, Yellow-Urgent, Green-Non-urgent and Black-Unsalvageable) included in the triage categories.</li>
</ul>
<p><strong>Table:</strong> Triage categories</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 14.3902%;" width="109">
<p><strong>Priority</strong></p>
</td>
<td style="width: 19.0244%;" width="144">
<p><strong>Medical need</strong></p>
</td>
<td style="width: 10.3252%;" width="78">
<p><strong>Color</strong></p>
</td>
<td style="width: 22.9268%;" width="174">
<p><strong>Clinical status</strong></p>
</td>
<td style="width: 33.252%;" width="252">
<p><strong>&nbsp;Examples</strong></p>
</td>
</tr>
<tr>
<td style="width: 14.3902%;" width="109">
<p><strong>First (I)</strong></p>
</td>
<td style="width: 19.0244%;" width="144">
<p>Immediate</p>
</td>
<td style="width: 10.3252%;" width="78">
<p>Red</p>
</td>
<td style="width: 22.9268%;" width="174">
<p>Critical, but likely to survive if treatment given early</p>
</td>
<td style="width: 33.252%;" width="252">
<ul>
<li>Tension pneumothorax</li>
<li>Severe facial trauma</li>
<li>Extradural hematomas</li>
<li>Hemothorax</li>
<li>Profuse external bleeding</li>
<li>Major intra-abdominal bleed</li>
<li>Flail chest</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 14.3902%;" width="109">
<p><strong>Second (II)</strong></p>
</td>
<td style="width: 19.0244%;" width="144">
<p>Urgent</p>
</td>
<td style="width: 10.3252%;" width="78">
<p>Yellow</p>
</td>
<td style="width: 22.9268%;" width="174">
<p>Critical, likely to survive if treatment given within hours</p>
</td>
<td style="width: 33.252%;" width="252">
<ul>
<li>Pelvic fractures</li>
<li>Degloving injuries</li>
<li>Compound fractures</li>
<li>Spinal injuries</li>
<li>Ruptured abdominal viscus</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 14.3902%;" width="109">
<p><strong>Third (III)</strong></p>
</td>
<td style="width: 19.0244%;" width="144">
<p>Non-urgent</p>
</td>
<td style="width: 10.3252%;" width="78">
<p>Green</p>
</td>
<td style="width: 22.9268%;" width="174">
<p>Stable, likely to survive even if treatment is delayed for hours to days</p>
</td>
<td style="width: 33.252%;" width="252">
<ul>
<li>Minor lacerations</li>
<li>Sprains</li>
<li>Simple fractures</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 14.3902%;" width="109">
<p><strong>Last (0)</strong></p>
</td>
<td style="width: 19.0244%;" width="144">
<p>Unsalvageable</p>
</td>
<td style="width: 10.3252%;" width="78">
<p>Black</p>
</td>
<td style="width: 22.9268%;" width="174">
<p>Not breathing, pulseless, so severely injured that no medical care is likely to help</p>
</td>
<td style="width: 33.252%;" width="252">
<ul>
<li>Severe brain damage</li>
<li>Major disruption/loss of chest or abdominal wall structures</li>
<li>Very extensive burns</li>
</ul>
</td>
</tr>
</tbody>
</table>
<p><img title="image002.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f3bd201c-b013-49bf-ba3a-0ddd4e3d1a79.png" alt="" width="358" height="261" /></p>
<p><strong>Figure: </strong>Triage and Color Code</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 2</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The side effect of chloramphenicol drug is: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bone marrow suppression</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Epilepsy</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Osteoporosis</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Weight gain</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Chloramphenicol inhibits the <strong>transpeptidase</strong> reaction by acting on 50s subunit ribosome.</li>
<li>It is a <strong>wide spectrum</strong> drug with activity against both gram positive and negative organisms, but use is limited by grave side-effects like <strong>bone marrow suppression and grey baby syndrome</strong>.</li>
<li>It is used as a reserve drug for treatment of resistant <em> influenza</em> and severe Rickettsial disease.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 3</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Normal respiration in adults is:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10 beats/min</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>14 beats/min</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>30 beats/min</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>8 beats/min</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Normal Breathing</strong></p>
<p><strong><img title="image004.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/dfb99e7c-e2df-4d01-9828-959f813f5546.jpg" alt="" width="250" height="32" /></strong></p>
<p><strong>Figure: Normal Breathing Pattern</strong></p>
<ul>
<li>Regular and comfortable.</li>
<li>12 - 20 beats per minute.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 4</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The full form of DPT is:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Dengue, pertussis, tetanus</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diphtheria, pneumonia, tetanus</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diphtheria, pertussis, tetanus</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diphtheria, pertussis, typhoid</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Store diphtheria, tetanus and pertussis vaccines refrigerated between 2&deg;C and 8&deg;C (36&deg;F and 46&deg;F).</li>
<li>Do not freeze vaccine or expose to freezing temperatures.</li>
<li>If the vaccine has been exposed to inappropriate conditions/temperatures or handled improperly: Store the vaccine at the appropriate temperature.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 5</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the dose of iron and folic acid in the Anemia Mukt Bharat Scheme?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>50 mg and 500 mcg</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>60 mg and 500 mcg</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>50 mg and 400 mcg</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>40 mg and 500 mcg</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Anemia Mukt Bharat</strong></p>
<p><img title="image006.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/1c09640a-bb1d-4cd3-996a-d707844ea94d.png" alt="" width="307" height="260" /></p>
<p><strong>Figure: Anemia Mukt Bharat</strong></p>
<ul>
<li>The strategy depicted in the image is 6&times;6&times;6 for Anemia Mukt Bharat.</li>
<li>Anemia Mukt Bharat strategy is focused on benefitting six target beneficiary groups, through six interventions and six institutional mechanisms to achieve the envisaged target of anemia reduction under the POSHAN Abhiyaan.</li>
<li><strong>Key highlights of the strategy:</strong>
<ul>
<li>Provision of supervised biweekly iron-folic acid (IFA) supplementation by the ASHA for all under-five children.</li>
<li>Weekly IFA supplementation for 5 - 10 years old children.</li>
<li>Annual/biannual deworming (children and adolescents).</li>
<li>Point of care testing (POCT) and treatment for in-school adolescents and pregnant women using newer technologies.</li>
<li>Establishing institutional mechanisms for advanced research in anemia.</li>
<li>Addressing non-nutritional causes of anemia.</li>
<li>Setting a comprehensive communication strategy including mass/mid media/social media communication material (radio and TV spots, posters, job-aids, interpersonal communication material.</li>
</ul>
</li>
</ul>
<p><strong>Table: </strong>Prophylactic dose and regime for Iron Folic Acid supplementation</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 34.5324%;" width="223">
<p><strong>Age group</strong></p>
</td>
<td style="width: 65.4676%;" width="484">
<p><strong>Dose and regime</strong></p>
</td>
</tr>
<tr>
<td style="width: 34.5324%;" width="223">
<p>Children 6 - 59 months of age</p>
</td>
<td style="width: 65.4676%;" width="484">
<p>Bi-weekly 1 mL Iron and Folic Acid syrup. Each mL of Iron and Folic Acid syrup contains 20 mg elemental Iron + 100 mcg of Folic Acid. Bottle (50mL) to have an &lsquo;auto-dispenser&rsquo; and information leaflet as per MoHFW guidelines in the mono-carton.</p>
</td>
</tr>
<tr>
<td style="width: 34.5324%;" width="223">
<p>Children 5 - 9 years of age</p>
</td>
<td style="width: 65.4676%;" width="484">
<p>Weekly, 1 Iron and Folic Acid tablet. Each tablet containing 45 mg elemental Iron + 400 mcg Folic Acid, sugar-coated, pink-color</p>
</td>
</tr>
<tr>
<td style="width: 34.5324%;" width="223">
<p>School-going adolescent girls and boys, 10 - 19 years of age out-of-school adolescent girls, 10 - 19 years of age</p>
</td>
<td style="width: 65.4676%;" width="484">
<p>Weekly, 1 Iron and Folic Acid tablet. Each tablet containing 60 mg elemental Iron + 500 mcg Folic Acid, sugar-coated, blue-color.</p>
</td>
</tr>
<tr>
<td style="width: 34.5324%;" width="223">
<p>Women of reproductive age (non-pregnant, non-lactating) 20 - 49 years (Under Mission Parivar Vikas)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
</td>
<td style="width: 65.4676%;" width="484">
<p>Weekly, 1 Iron and Folic Acid tablet. Each tablet containing <strong>60 mg elemental Iron + 500 mcg Folic Acid</strong>, sugar-coated and red-color.</p>
</td>
</tr>
<tr>
<td style="width: 34.5324%;" width="223">
<p>Pregnant Women and Lactating Mothers (of 0 - 6 months child)</p>
</td>
<td style="width: 65.4676%;" width="484">
<p>Daily, 1 Iron and Folic Acid tablet starting from the fourth month of pregnancy (that is from the second trimester), continued throughout pregnancy (minimum 180 days during pregnancy) and to be continued for 180 days, post-partum Each tablet containing 60 mg elemental Iron + 500 mcg Folic Acid, sugar-coated and red-color.</p>
</td>
</tr>
</tbody>
</table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 6</h3>
                <p><b>What is baking powder?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Sodium chloride</li><li>2. Sodium bicarbonate</li><li>3. Potassium bicarbonate</li><li>4. Potassium chloride</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>Baking soda and baking powder are amongst the most common kitchen ingredients. These are primarily used as leavening agents or raising agents in doughs and batters.</li><li>Baking soda is a sodium salt with the chemical name Sodium Bicarbonate. The chemical formula of baking soda is NaHCO<sub>3</sub>. As the formula suggests, it comprises of Na<sup>+</sup> and HCO<sub>3</sub><sup>-</sup></li></ul></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 7</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The most common type of episiotomy is: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Right mediolateral</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>J shaped</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lateral</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Median</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The <strong>most common episiotomy in the US is performed on the midline</strong>, which is directly above your anus.</li>
<li>The <strong>second kind of episiotomy is called mediolateral</strong> and is cut slightly to one side or the other of your perineum. A mediolateral episiotomy is more common in other parts of the world.</li>
</ul>
<p><strong>Episiotomy </strong></p>
<ul>
<li>This is a surgical incision made in the perineum to enlarge the vaginal opening and assist in childbirth.</li>
<li>It used to be performed in &gt;30% of vaginal deliveries, most often in nulliparous women, but there was a steep decline to &lt;10% by 2006.</li>
<li><strong>Indications for an episiotomy: </strong>
<ul>
<li>To expedite delivery in the setting of non-reassuring fetal heart tracing or maternal exhaustion.</li>
<li>In elastic (rigid) perineum: Elderly primigravida.</li>
<li>Shoulder dystocia (to facilitate operator maneuvers)</li>
<li>Big baby</li>
<li>Breech delivery</li>
<li>Face to pubis delivery</li>
<li>Operative vaginal delivery (forceps or vacuum)</li>
<li>OP positions</li>
</ul>
</li>
<li><strong>Timing of Episiotomy:</strong> Bulging thinned perineum during contraction just prior to crowning (when 3 - 4 cm of head is visible) is the ideal time to give episiotomy.</li>
<li><strong>Goal:</strong> Episiotomy was introduced to reduce complications of pelvic floor trauma at delivery, including bleeding, infection, genital prolapse and incontinence.</li>
<li><strong>Types of Episiotomy:</strong></li>
</ul>
<p><strong><img title="image007.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/d43abbbb-a620-4f92-8eae-a7c84aa61091.jpg" alt="" width="668" height="142" /></strong></p>
<p><strong>Figure: Types of Episiotomy </strong></p>
<p><strong>Table: Types of Episiotomy &nbsp;</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 48.0216%;" width="334">
<p><strong>Midline episiotomy</strong></p>
</td>
<td style="width: 51.9784%;" width="354">
<p><strong>Mediolateral episiotomy</strong></p>
</td>
</tr>
<tr>
<td style="width: 48.0216%;" width="334">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Midline episiotomy refers to a vertical midline incision from Then, posterior Fourchette toward the rectum.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Muscles are not cut.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Blood loss is less.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Repair is easy. &nbsp;</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; It is effective in hastening delivery, but is associated with increased severe perineal trauma involving the external anal sphincter (third and fourth degree extensions).</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Incisions cannot be extended. &nbsp;</p>
<p>&nbsp;</p>
</td>
<td style="width: 51.9784%;" width="354">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Mediolateral episiotomy is cut at 45&deg; to the posterior Fourchette on one side.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Muscles are cut.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; It is associated with increased blood loss, wound infection and worsened postpartum pain (none of which has been definitively demonstrated).</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Dyspareunia is more than Midline episiotomy.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Such incisions appear to protect against severe perineal trauma.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Repair is difficult.</p>
</td>
</tr>
</tbody>
</table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 8</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following blood group is a universal donor?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>O Positive</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>O Negative</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>AB positive</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>AB negative</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Type AB-positive blood is called the "universal recipient" type because a person who has it can receive blood of any type.</li>
<li>Type O-negative blood does not have any antigens. It is called the "universal donor" type because it is compatible with any blood type.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 9</h3>
                <p><b>Loud and harsh lung sound is known as:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Stridor</li><li>2. Wheezing</li><li>3. Rhonchi</li><li>4. Snoring</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Stridor is a high-pitched sound originating from the upper airway and occurring on inspiration. It is distinguished from other sounds by its intensity in the neck more so than the chest, timing (inspiratory) and pitch (high). Like wheezes, stridor is produced by airway narrowing, but only in the upper airways</li><li>Rhonchi (a low-pitched breath sound) crackles (a high-pitched breath sound) wheezing (a high-pitched whistling sound caused by narrowing of the bronchial tubes) stridor (a harsh, vibratory sound caused by narrowing of the upper airway).</li><li><b>Wheeze:</b> These are the high-pitched sounds generated when the air is passing through the severely narrowed or obstructed airways in the lungs. Auscultated during both inspiration and expiration; louder during expiration.</li><li><b>Rhonchi:</b> Also called sonorous wheeze. It is low pitched and loud enough to be heard over all the lobes of the lungs, but usually heard over the bronchi and trachea. It is generated due to any muscular spasm, large amounts of mucus inside the lungs, and may get cleared during coughing. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 10</h3>
                <p><b>Rapid and weak pulse is known as: </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Bounding pulse</li><li>2. Thready pulse</li><li>3. Strong pulse</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li><b>Thready pulse:</b> a scarcely perceptible and commonly rapid pulse that feels like a fine mobile thread under a palpating finger.</li><li>A thready pulse or weak pulse is one that is difficult to feel or obliterated easily with slight pressure.</li><li>A bounding pulse is a strong throbbing felt over one of the arteries in the body. It is due to a forceful heartbeat.</li><li>A weak pulse means you have difficulty feeling a personâ€™s pulse (heartbeat).</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 11</h3>
                <p><b>Chances of PTSD are most common in:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Divorce</li><li>2. Diagnosis of cancer</li><li>3. Facing gunshot (means someone put the gun on skull)</li><li>4. Bank robbery</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Post-traumatic stress disorder is characterized by flashbacks, irritability, difficulty falling asleep and concentrating following an extremely traumatic event. This lasts for more than one month. </li><li>Posttraumatic stress disorder (PTSD) is a syndrome that results from exposure to real or threatened death, serious injury, or sexual assault. Following the traumatic event, PTSD is common and is one of the serious health concerns that is associated with comorbidity, functional impairment and increased mortality with suicidal ideations and attempts.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 12</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Projective technique is used for the assessment of:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Memory</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Intelligence</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Knowledge</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Personality</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><img title="image010.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/bfcdea30-3af2-4d47-b4a3-94cd4886549b.png" alt="" width="225" height="153" /></p>
<p><strong>Figure: Rorschach Ink- Blot</strong></p>
<ul>
<li>The given test depicted in the image is Rorschach Ink&ndash;Blot.</li>
<li>Rorschach inkblot test, <strong>projective method of psychological testing</strong> in which a person is asked to describe what he or she sees in 10 inkblots, of which some are black or gray and others have patches of color. The test was introduced in 1921 by Swiss psychiatrist Hermann Rorschach.</li>
<li>It is the second most commonly used forensic test after the Minnesota Multiphasic Personality Inventory (MMPI-2).</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 13</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What differentiates mania from hypomania? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Psychotic symptoms</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Reduced sleeping time</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Effect on work</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Need for hospital admission</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Mania is due to masked depression. Some other hallmarks of mania are an elevated or expansive mood, mood lability, impulsivity, irritability and grandiosity. If the individual experiencing these symptoms require hospitalization, Then, this period automatically qualifies as true mania and not hypomania, even if the symptoms are present for less than one week.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 14</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong>Which screening test is not used for cervical cancer?</strong></p>
</body></html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Colposcopy</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>HPV DNA</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pap smear</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>VIA</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The screening test <strong>not</strong> used for cervical cancer is: <strong> Colposcopy</strong></li>
<li>Colposcopy is a diagnostic procedure used when there are abnormal results from screening tests (like Pap smear or HPV test) to examine the cervix more closely, rather than being a screening test itself.</li>
<li>The other options (HPV DNA, Pap smear, and VIA) are commonly used in cervical cancer screening.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 15</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>X does not use a car while going out, scared of using lifts. He avoids going in public places and keeps the doors open while in a closed room. He finds it uncomfortable to leave the house alone, so he always takes a family member along whenever he goes out. What will be the probable diagnosis? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Claustrophobia</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Agoraphobia</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Public phobia</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Aerophobia</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Agoraphobia is characterized by a fear of situations where escape might be difficult or help unavailable in case of panic-like symptoms. This includes avoiding public places, being afraid to leave the house alone, and avoiding certain places or situations, such as lifts and closed rooms, which is consistent with the symptoms described in the case.</li>
<li><strong>Claustrophobia:</strong> This is the fear of being in enclosed or confined spaces, such as elevators, small rooms, or tight spaces. While Mr. X does avoid closed spaces (e.g., keeping doors open in a closed room), his symptoms are broader and more related to fear of going out or being in public places, which makes agoraphobia a better fit.</li>
<li><strong>Public phobia:</strong> This is not a specific clinical diagnosis in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). However, it might refer to social anxiety or social phobia, where individuals fear being in social situations or being negatively judged by others. Mr. X&rsquo;s fear seems more focused on specific situations (e.g., going out alone, using lifts) rather than social interactions or fear of being judged, so this is not the right diagnosis. &nbsp;&nbsp;&nbsp;</li>
<li><strong>Aerophobia:</strong> Aerophobia is the fear of flying. There&rsquo;s no mention of Mr. X having a fear of airplanes or flying, so this does not align with the symptoms described in the question.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 16</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which vaccine is not included in Indradhanush Program? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>DPT</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hepatitis b</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pneumococcal vaccine</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Measles</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The Mission Indradhanush, depicting seven colors of the rainbow, targets to immunize all children against seven vaccine preventable diseases namely:</li>
<li>Diphtheria</li>
<li>Pertussis</li>
<li>Tetanus</li>
<li>Childhood Tuberculosis</li>
<li>Polio</li>
<li>Hepatitis B</li>
<li>Measles</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 17</h3>
                <p><b>Which of the following is the longest bone of the body? </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Femur</li><li>2. Tibia</li><li>3. Fibula</li><li>4. Radius</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>The femur is the longest bone in the human body and the shortest bone is the stapes found in the middle ear.</li></ul><p><strong>Table:</strong> Summaries of Bone classification</p><table style="border-collapse: collapse; width: 100%;" border="1"><tbody><tr><td style="width: 17.561%;" width="133"><p><strong>Bone classification</strong></p></td><td style="width: 18.374%;" width="139"><p><strong>&nbsp;Features</strong></p></td><td style="width: 31.5447%;" width="239"><p><strong>&nbsp;Examples</strong></p></td><td style="width: 32.439%;" width="246"><p><strong>Function(s)</strong></p></td></tr><tr><td style="width: 17.561%;" width="133"><p>Long</p></td><td style="width: 18.374%;" width="139"><p>Cylinder-like shape, longer than it is wide</p></td><td style="width: 31.5447%;" width="239"><p>Femur, tibia, fibula, metatarsals, humerus, ulna, radius, metacarpals, phalanges</p></td><td style="width: 32.439%;" width="246"><p>Movement, support</p></td></tr><tr><td style="width: 17.561%;" width="133"><p>Short</p></td><td style="width: 18.374%;" width="139"><p>Cube-like shape, approximately equal in length, width and thickness</p></td><td style="width: 31.5447%;" width="239"><p>Carpals, tarsals</p></td><td style="width: 32.439%;" width="246"><p>Provide stability, support, while allowing for some motion</p></td></tr><tr><td style="width: 17.561%;" width="133"><p>Flat</p></td><td style="width: 18.374%;" width="139"><p>Thin and curved</p></td><td style="width: 31.5447%;" width="239"><p>Sternum, ribs, scapulae, cranial bones</p></td><td style="width: 32.439%;" width="246"><p>Points of attachment for muscles; protectors of internal organs</p></td></tr><tr><td style="width: 17.561%;" width="133"><p>Irregular</p></td><td style="width: 18.374%;" width="139"><p>Complex shape</p></td><td style="width: 31.5447%;" width="239"><p>Vertebrae, facial bones</p></td><td style="width: 32.439%;" width="246"><p>Protect internal organs, movement, support</p></td></tr><tr><td style="width: 17.561%;" width="133"><p>Sesamoid</p></td><td style="width: 18.374%;" width="139"><p>Small and round; embedded in tendons</p></td><td style="width: 31.5447%;" width="239"><p>Patellae</p></td><td style="width: 32.439%;" width="246"><p>Protect tendons from excessive forces, allow effective muscle action</p></td></tr></tbody></table></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 18</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is the &ldquo;Breast bone&rdquo; in the given below bones? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sternum</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ribs</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Clavicle</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vertebrae</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The sternum is sometimes known as the breastbone.</li>
<li>This flat bone sits at the front of the chest and connects to the ribs with cartilage. The sternum is part of the rib cage, a series of bones that protects the heart and lungs from injuries.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 19</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is most uncommon in schizophrenia?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Thought broadcasting</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Visual hallucinations</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Thought (something was here)</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Delusion of reference</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Auditory hallucinations were by far the most common, followed by visual hallucinations and Then, by tactile and olfactory or gustatory hallucinations. Auditory hallucinations were associated with an earlier age of first hospitalization among the schizophrenics.</li>
<li><strong>Visual hallucinations are more common in delirium</strong>. They range from dream-like experiences to terrifying visions. Other types of hallucination may be present, but less common.</li>
<li>Thought Broadcasting is a psychotic symptom in which the patient has the experience that his or her thoughts are being broadcast aloud so that people around can hear the thoughts. This symptom is most common in bipolar disorder, schizoaffective disorder and schizophrenia.</li>
<li>According to the DSM-IV-TR, persecutory delusions are the most common form of delusions in schizophrenia, where the person believes they are "being tormented, followed, sabotaged, tricked, spied on, or ridiculed&rdquo;.</li>
<li>A delusion of reference is the belief that unrelated occurrences in the external world have a special significance for the person who is being diagnosed.</li>
<li>Symptoms of schizophrenia can be classified as positive or negative.</li>
<li>Anything abnormal added to a patient's life is a positive symptom and anything normal lost from a patient's life is a negative symptom.</li>
</ul>
<p><strong>Table: Symptoms of Schizophrenia </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 46.223%;" width="300">
<p><strong>Positive symptoms</strong></p>
</td>
<td style="width: 53.777%;" width="358">
<p><strong>Negative symptoms</strong></p>
</td>
</tr>
<tr>
<td style="width: 46.223%;" width="300">
<p>Hallucination Delusion Bizarre motor acts</p>
</td>
<td style="width: 53.777%;" width="358">
<p>Flattening of affect Anhedonia Alogia Apathy Paucity of thought Poverty of speech</p>
</td>
</tr>
<tr>
<td style="width: 46.223%;" width="300">
<p>Common in acute schizophrenia</p>
</td>
<td style="width: 53.777%;" width="358">
<p>Common in chronic schizophrenia</p>
</td>
</tr>
<tr>
<td style="width: 46.223%;" width="300">
<p>Hyperactivity of the dopaminergic system in the mesolimbic system</p>
</td>
<td style="width: 53.777%;" width="358">
<p>Hypoactivity of the dopaminergic system in the mesocortical system</p>
</td>
</tr>
<tr>
<td style="width: 46.223%;" width="300">
<p>Respond to most typical and atypical</p>
</td>
<td style="width: 53.777%;" width="358">
<p>Respond better to atypical antipsychotics</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 20</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A person is saying his family members are dying. He is also decaying, nothing exists in the world?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Delusion of persecution</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Paranoid delusion</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nihilistic delusion</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Delusion of reference</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Nihilistic delusions, also known as desires de negation, are specific psychopathological entities characterized by the delusional belief of being dead, decomposed or annihilated, having lost one's own internal organs or even not existing entirely as a human being.</li>
</ul>
<p><strong>Table: Types of delusions &nbsp;</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of control</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>False belief that a person's will, thoughts, or feelings are being controlled by external forces.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of grandeur or Megalomania</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>Exaggerated conception of one's importance, power, or identity.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of infidelity or morbid jealousy or Othello syndrome</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>False belief that one's lover is unfaithful. Sometimes called pathological jealousy.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of love or erotomania</p>
<p>&nbsp;</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>False belief that another person is in love with them. In De Clerambault syndrome, the woman believes that a man, frequently older and of higher status, is in love with her.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of misidentification</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Capgras syndrome:</strong> Belief that a familiar person has been replaced by an exact double i.e. an impostor.</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Fregoli syndrome:</strong> Person holds a delusional belief that different people are in fact a single person who changes his or her appearance or is in disguise.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Nihilistic delusion</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>False belief that oneself, others or the world, is non-existent or about to end. When nihilistic delusion is accompanied by ideas concerning bodily function failure e.g. putrefaction of intestine etc., it is called Cotard syndrome.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of infestation</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>False belief that one is infested with small but visible organisms. As a monosymptomatic delusional disorder, this is called Ekbom syndrome.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of persecution</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>The most common delusion. False belief of being harassed or persecuted.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of poverty</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>The person strongly believes they are financially incapacitated.</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of reference</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>False belief that the behavior of others has a particular and unusual significance, usually of a negative nature. The person may falsely feel that others are talking about them (e.g. the people on television are talking to or about the person).</p>
</td>
</tr>
<tr>
<td style="width: 37.4101%;" width="259">
<p>Delusion of self-accusation</p>
</td>
<td style="width: 62.5899%;" width="504">
<p>False feeling of remorse and guilt. Seen in depression with psychotic features.</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 21</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Placenta is discarded in ___________color bag.</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Red</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Yellow</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Blue</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Black</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Bio-Medical waste such as anatomical waste, placenta, tissues, body parts, etc. should be placed in the Yellow Bins.</li>
<li>In the Black Bin, all expired drugs and cytotoxic drugs, etc. should be placed.</li>
<li>Non-plastic waste (used cotton, gauze, soiled bandages) should be placed in red bin with small bio-hazard symbol inside the small red bin.</li>
<li>Bio-Medical Waste such as sharps including ampoules, vials, broken glasses, suture, slides, etc. should be placed in the Blue Bin. Needles and suture lancets should be managed by using needle destroyer. &nbsp;</li>
<li>General Waste such as food items, plastic covers, needle covers and infected Plaster of Paris, etc. should be placed in the green bins.</li>
</ul>
<p><strong>Table 1: Categories of Biomedical Wastes (BMW)</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>Cat</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p><strong>&nbsp;BMW</strong></p>
</td>
<td style="width: 57.9137%;" width="474">
<p><strong>&nbsp;Waste Included</strong></p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>1</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Human anatomical waste</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Human tissue, organs, body parts</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>2</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Animal waste</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Animal tissues, body parts, organs, carcasses, fluids, Blood</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>3</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Microbiology and biotechnology waste</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Waste from lab cultures, stocks, specimens of microorganisms, live or attenuated vaccine, cell cultures (Human/Animal), wastes from production of biological, Toxins</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>4</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Waste sharps</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Needles, syringes, blades, scalpels, glass</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>5</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Discarded medicine and cytotoxic drugs</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Outdated contaminated and discarded drugs</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>6</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Soiled waste</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Items contaminated with blood and fluids, including cotton, dressings, soiled plaster casts, linen, beddings.</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>7</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Solid waste</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Disposable items (except sharps) including tubing, catheters, intravenous sets</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>8</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Liquid waste</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Waste generated from lab, washing, cleaning, housekeeping and disinfecting activities.</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>9</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Incineration ash</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Ash from incineration of any BMW</p>
</td>
</tr>
<tr>
<td style="width: 10.4317%;" width="61">
<p><strong>10</strong></p>
</td>
<td style="width: 31.6547%;" width="216">
<p>Chemical waste</p>
</td>
<td style="width: 57.9137%;" width="474">
<p>Chemical used in disinfection (insecticides) or in production of biological.</p>
</td>
</tr>
</tbody>
</table>
<p><strong>New Biomedical Waste Management Guidelines 2015 - 16</strong></p>
<ul>
<li>Ministry: Ministry of Environment and Forest</li>
<li>Legislation: Section 6, 8 and 25 of Environment [protection Act, 1986].</li>
<li>These rules shall not apply to radioactive wastes, hazardous chemical, municipal solid wastes, lead acid batteries, hazardous wastes, e-waste, hazardous microorganisms, genetically engineering microorganisms.</li>
</ul>
<p><strong>Table 2: Biomedical Waste Management </strong></p>
<table style="border-collapse: collapse; width: 93.7163%; height: 1944px;" border="1">
<tbody>
<tr>
<td style="width: 19.0647%;" width="115">
<p><strong>Category</strong></p>
</td>
<td style="width: 24.2806%;" width="236">
<p><strong>&nbsp;Type of Wastes</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p><strong>&nbsp;Bag/ Container</strong></p>
</td>
<td style="width: 38.4892%;" width="259">
<p><strong>Treatment / Disposal</strong></p>
</td>
</tr>
<tr>
<td style="width: 19.0647%;" rowspan="6" width="115">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Yellow</strong></p>
</td>
<td style="width: 24.2806%;" width="236">
<p><strong>Human Anatomical waste</strong></p>
<p><strong>Animal Anatomical waste</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p>Yellow non-chlorinated plastic bags</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Incineration/ Plasma pyrolysis/ Deep burial</p>
</td>
</tr>
<tr>
<td style="width: 24.2806%;" width="236">
<p><strong>&nbsp;Solid waste</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p>&nbsp;</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Incineration/ Plasma pyrolysis/ Deep burial OR</p>
<p>autoclaving/ microwaving / Hydroclaving</p>
<p>Then,</p>
<p>Shredding / Mutilation</p>
</td>
</tr>
<tr>
<td style="width: 24.2806%;" width="236">
<p><strong>Discarded medicine</strong></p>
<p><strong>Chemical waste</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p>Yellow non-chlorinated plastic bags</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Incineration/Encapsulation/ Plasma pyrolysis</p>
</td>
</tr>
<tr>
<td style="width: 24.2806%;" width="236">
<p><strong>Chemical liquid waste</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p>Separate collection system leading to effluent treatment system.</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Pretreatment</p>
<p>Then,</p>
<p>Drain</p>
</td>
</tr>
<tr>
<td style="width: 24.2806%;" width="236">
<p><strong>Discarded linen, mattresses, bedding contaminated with blood or body fluid</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p>Yellow non-chlorinated plastic bags or suitable packing material</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Non-chlorinated chemical disinfection</p>
<p>Then,</p>
<p>Incineration/ Plasma pyrolysis / Energy recovery or Shredding / Mutilation</p>
</td>
</tr>
<tr>
<td style="width: 24.2806%;" width="236">
<p><strong>Microbiology biotechnology clinical laboratory waste</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p>Autoclave safe plastic bags or containers</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Pre-treat with Non-chlorinated chemicals</p>
<p>Then,</p>
<p>Incineration</p>
</td>
</tr>
<tr>
<td style="width: 19.0647%;" width="115">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>&nbsp;</strong><strong>Red</strong></p>
</td>
<td style="width: 24.2806%;" width="236">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Contaminated waste (Recyclable)</strong></p>
</td>
<td style="width: 18.1655%;" width="158">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Red non-chlorinated plastic bags or containers</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Autoclaving/ microwaving / Hydroclaving</p>
<p>Then,</p>
<p>Shredding / Mutilation</p>
<p>Then,</p>
<p>Energy recovery / Plastic to diesel or fuel oil / Road making</p>
</td>
</tr>
<tr>
<td style="width: 19.0647%;" width="115">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>White</strong></p>
<p>(Translucent)</p>
</td>
<td style="width: 24.2806%;" width="236">
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>Waste sharp including metals</p>
</td>
<td style="width: 18.1655%;" width="158">
<p>&nbsp;</p>
<p>Puncture proof, leak proof, Tamper proof container</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Autoclaving/ Dry heat</p>
<p>Then,</p>
<p>Shredding / Mutilation/ Encapsulation</p>
<p>Then,</p>
<p>Iron foundries / Sanitary landfill / Waste sharp pit</p>
</td>
</tr>
<tr>
<td style="width: 19.0647%;" width="115">
<p>&nbsp;</p>
<p><strong>&nbsp;</strong></p>
<p><strong>&nbsp;Blue</strong></p>
</td>
<td style="width: 24.2806%;" width="236">
<p>&nbsp;</p>
<p>&nbsp;Glassware</p>
<p>Metallic body implants</p>
</td>
<td style="width: 18.1655%;" width="158">
<p>Cardboard boxes with blue colored marking</p>
</td>
<td style="width: 38.4892%;" width="259">
<p>Sodium hypochlorite/ Autoclaving/ Microwaving/ Hydroclaving</p>
<p>Then,</p>
<p>Recycling</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 22</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which measure is used for growth monitoring at Anganwadi center? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Weight for height</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>MUAC</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Skin fold thicknesses</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Weight for age</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Weight&ndash;for-age growth chart standards have been prescribed at the Anganwadi Centre for all children below six years of age (as per WHO Child Growth Standards).</li>
<li>Children under three years of age are to be weighed once a month and children 3 - 6 years of age are weighed quarterly.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 23</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is not a sign of good attachment?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Upper side areola more exposed than lower</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Widely open mouth</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chin touches the breast</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Lower lip move inward</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Technique of Breastfeeding </strong></p>
<ul>
<li><strong>Position of the Baby</strong></li>
<li>Baby's whole body is supported, not just neck or shoulders.</li>
<li>Baby's head and body are in one line without any twist in the neck</li>
<li>Baby's body turned towards the mother (abdomen of the baby and the mother touching each other).</li>
<li>Baby's nose is at the level of the nipple.</li>
</ul>
<p><img title="image013.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/4f9b857e-18d2-4d4a-af50-8c09106aafb4.jpg" alt="" width="188" height="188" /> <img title="image012.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/cfc49ad2-053f-4107-8583-a7059b814221.jpg" alt="" width="311" height="174" /></p>
<p><strong>Figure: Latching </strong></p>
<ul>
<li><strong>Signs of Good Attachment: (Latching)</strong></li>
<li>The baby's mouth is wide open.</li>
<li>Most of the nipple and areola in the mouth, only upper areola visible, not the lower one.</li>
<li>The baby's chin touches the breast.</li>
<li>The baby's lower lip is everted.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 24</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the range of MUAC for malnutrition?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>&lt;12.5 cm</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>&lt;11.5 cm</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>&lt;13.5 cm</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>&lt;14.5 cm</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Table: Diagnosis of Malnutrition </strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 49.8201%;" width="353">
<p><strong>&nbsp;&nbsp;MAC</strong></p>
</td>
<td style="width: 50.1799%;" width="353">
<p><strong>&nbsp;Bangle test</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.8201%;" rowspan="3" width="353">
<p>&bull; &nbsp;It is the circumference of the left upper arm, measured at the mid-point between the tip of the shoulder and the tip of the elbow (Olecranon process and the acromium).</p>
<p>&bull; &nbsp;Normal value is 16 - 17 cm in age group of 1 - 5 years</p>
<p>&bull; &nbsp;&lt; 13.5: Borderline malnutrition</p>
<p>&bull; &nbsp;&lt; 11. 5: Severe acute malnutrition</p>
</td>
<td style="width: 50.1799%;" width="353">
<p>&bull;&nbsp; In case of malnutrition a bangle of 4 cm diameter passes above elbow</p>
</td>
</tr>
<tr>
<td style="width: 50.1799%;" width="353">
<p>&nbsp;<strong>Shakir tape method </strong></p>
</td>
</tr>
<tr>
<td style="width: 50.1799%;" width="353">
<p>&bull; &nbsp;This special tape has colored zones: red, yellow and green corresponding to &lt; 12.5 cm (wasted), 12.5 - 13.5 cm (borderline) and over 13.5 cm (normal) MUAC respectively.</p>
<p>&nbsp;<img title="image016.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/24eab9ed-7ab9-4b33-8e6f-4461f240f081.jpg" alt="" width="261" height="160" /></p>
<p><strong>&nbsp;</strong></p>
<p><strong>Figure 1: Shakir tape</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.8201%;" width="353">
<p><strong>&nbsp;Skin fold thickness</strong></p>
</td>
<td style="width: 50.1799%;" width="353">
<p><strong>&nbsp;Ratios</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.8201%;" width="353">
<p>&bull; &nbsp;It is an indicator of subcutaneous fat.</p>
<p>&bull; &nbsp;A skin fold thickness in triceps above 10 mm is normal and below 6 mm indicates malnutrition.</p>
<p>&bull; &nbsp;It is measured using <strong>Harpenden caliper</strong>.</p>
<p>&nbsp;<img title="image018.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/5fb6635e-d45d-40f6-98f4-f0b63c956f18.jpg" alt="" width="228" height="128" />&nbsp;</p>
<p><strong>Figure 2: Harpenden caliper</strong></p>
</td>
<td style="width: 50.1799%;" width="353">
<p>&bull; &nbsp;Kanawati index</p>
<p>&bull; &nbsp;Dagdale&rsquo;s index</p>
<p>&bull; &nbsp;Quaker arm circumference</p>
<p>&bull; &nbsp;Jeliffe&rsquo;s Ratio</p>
<p>&bull; &nbsp;Rao and Singh</p>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 25</h3>
                <p><b>A cotton ball infected with pus is discarded in which colored bin? </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Yellow</li><li>2. Black</li><li>3. Red</li><li>4. Blue</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>Bio-Medical waste such as anatomical waste, placenta, tissues, body parts, etc. should be placed in the Yellow Bins.</li><li>In the Black Bin, all expired drugs and cytotoxic drugs, etc. should be placed.</li><li>Non-plastic waste (used cotton, gauze, soiled bandages) should be placed in red bin with small bio-hazard symbol inside the small red bin.</li><li>Bio-Medical Waste such as sharps including ampoules, vials, broken glasses, suture, slides, etc. should be placed in the Blue Bin. Needles and suture lancets should be managed by using needle destroyer.</li><li>General Waste such as food items, plastic covers, needle covers and infected plaster of paris, etc. should be placed in the green bins.</li></ul><p><strong>Table 1:</strong> Categories of Biomedical Wastes (BMW)</p><table style="border-collapse: collapse; width: 100%;" border="1"><tbody><tr><td style="width: 8.13008%;" width="61"><p><strong>Cat</strong></p></td><td style="width: 28.6992%;" width="216"><p><strong>&nbsp;BMW</strong></p></td><td style="width: 63.0894%;" width="474"><p><strong>&nbsp;Waste Included</strong></p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>1</strong></p></td><td style="width: 28.6992%;" width="216"><p>Human Anatomical waste</p></td><td style="width: 63.0894%;" width="474"><p>Human tissue, organs, body parts</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>2</strong></p></td><td style="width: 28.6992%;" width="216"><p>Animal waste</p></td><td style="width: 63.0894%;" width="474"><p>Animal tissues, body parts, organs, carcasses, fluids, Blood</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>3</strong></p></td><td style="width: 28.6992%;" width="216"><p>Microbiology and Biotechnology Waste</p></td><td style="width: 63.0894%;" width="474"><p>Waste from lab cultures, stocks, specimens of microorganisms, live or attenuated vaccine, cell cultures (Human/ Animal), wastes from production of biological, Toxins</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>4</strong></p></td><td style="width: 28.6992%;" width="216"><p>Waste Sharps</p></td><td style="width: 63.0894%;" width="474"><p>Needles, Syringes, Blades, Scalpels, Glass</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>5</strong></p></td><td style="width: 28.6992%;" width="216"><p>Discarded Medicine and Cytotoxic Dugs</p></td><td style="width: 63.0894%;" width="474"><p>Outdated contaminated and discarded drugs</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>6</strong></p></td><td style="width: 28.6992%;" width="216"><p>Soiled Waste</p></td><td style="width: 63.0894%;" width="474"><p>Items contaminated with blood and fluids, including cotton, dressings,, soiled plaster casts, linen, beddings.</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>7</strong></p></td><td style="width: 28.6992%;" width="216"><p>Solid waste</p></td><td style="width: 63.0894%;" width="474"><p>Disposable items (except sharps) including tubing, catheters, intravenous sets</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>8</strong></p></td><td style="width: 28.6992%;" width="216"><p>Liquid Waste</p></td><td style="width: 63.0894%;" width="474"><p>Waste generated from lab and washing cleaning housekeeping and disinfecting activities.</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>9</strong></p></td><td style="width: 28.6992%;" width="216"><p>Incineration Ash</p></td><td style="width: 63.0894%;" width="474"><p>Ash from incineration of any BMW</p></td></tr><tr><td style="width: 8.13008%;" width="61"><p><strong>10</strong></p></td><td style="width: 28.6992%;" width="216"><p>Chemical Waste</p></td><td style="width: 63.0894%;" width="474"><p>Chemical used in disinfection (insecticides) or in production of biological.</p></td></tr></tbody></table><p><strong>New Biomedical Waste Management Guidelines 2015 - 16</strong></p><ul><li>Ministry: Ministry of Environment and Forest</li><li>Legislation: Section 6, 8 and 25 of Environment [protection Act, 1986.</li><li>These rules shall not apply to Radioactive wastes, Hazardous chemical, Municipal solid wastes, Lead acid batteries, Hazardous wastes, e-waste, Hazardous microorganisms, genetically engineering microorganisms.</li></ul><p><strong>Table 2:</strong> Biomedical Waste Management</p><table style="border-collapse: collapse; width: 100%;" border="1"><tbody><tr><td style="width: 13.9837%;" width="96"><p><strong>Category</strong></p></td><td style="width: 30.0813%;" width="210"><p><strong>&nbsp;Type of Wastes</strong></p></td><td style="width: 24.878%;" width="174"><p><strong>&nbsp;Bag/ Container</strong></p></td><td style="width: 30.8943%;" width="216"><p><strong>Treatment / Disposal</strong></p></td></tr><tr><td style="width: 13.9837%;" rowspan="6" width="96"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>YELLOW</strong></p></td><td style="width: 30.0813%;" width="210"><p><strong>Human Anatomical waste</strong></p><p><strong>Animal Anatomical waste</strong></p></td><td style="width: 24.878%;" width="174"><p>Yellow non-chlorinated plastic bags</p></td><td style="width: 30.8943%;" width="216"><p>Incineration/ Plasma pyrolysis/ Deep burial</p></td></tr><tr><td style="width: 30.0813%;" width="210"><p><strong>&nbsp;Solid waste</strong></p></td><td style="width: 24.878%;" width="174"><p>&nbsp;</p></td><td style="width: 30.8943%;" width="216"><p>Incineration/ Plasma pyrolysis/ Deep burial OR</p><p>autoclaving/ microwaving / Hydroclaving</p><p>THEN</p><p>Shredding / Mutilation</p></td></tr><tr><td style="width: 30.0813%;" width="210"><p><strong>Discarded Medicine</strong></p><p><strong>Chemical Waste</strong></p></td><td style="width: 24.878%;" width="174"><p>Yellow non-chlorinated plastic bags</p></td><td style="width: 30.8943%;" width="216"><p>Incineration/Encapsulation/ Plasma pyrolysis</p></td></tr><tr><td style="width: 30.0813%;" width="210"><p><strong>Chemical liquid Waste</strong></p></td><td style="width: 24.878%;" width="174"><p>Separate collection system leading to effluent treatment system.</p></td><td style="width: 30.8943%;" width="216"><p>Pretreatment</p><p>THEN</p><p>Drain</p></td></tr><tr><td style="width: 30.0813%;" width="210"><p><strong>Discarded linen, mattresses, bedding contaminated with blood or body fluid</strong></p></td><td style="width: 24.878%;" width="174"><p>Yellow non-chlorinated plastic bags or suitable packing material</p></td><td style="width: 30.8943%;" width="216"><p>Non-chlorinated chemical disinfection</p><p>THEN</p><p>Incineration/ Plasma pyrolysis / Energy recovery or Shredding / Mutilation</p></td></tr><tr><td style="width: 30.0813%;" width="210"><p><strong>Microbiology Biotechnology clinical laboratory waste</strong></p></td><td style="width: 24.878%;" width="174"><p>Autoclave safe plastic bags or containers</p></td><td style="width: 30.8943%;" width="216"><p>Pre-treat with Non-chlorinated chemicals</p><p>THEN,</p><p>Incineration</p></td></tr><tr><td style="width: 13.9837%;" width="96"><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>&nbsp;</strong><strong>RED</strong></p></td><td style="width: 30.0813%;" width="210"><p>&nbsp;</p><p>&nbsp;</p><p><strong>Contaminated waste (Recyclable)</strong></p></td><td style="width: 24.878%;" width="174"><p>&nbsp;</p><p>&nbsp;</p><p>Red non-chlorinated plastic bags or containers</p></td><td style="width: 30.8943%;" width="216"><p>Autoclaving/ microwaving / Hydroclaving</p><p>THEN</p><p>Shredding / Mutilation</p><p>THEN</p><p>Energy recovery / Plastic to diesel or fuel oil / Road making</p></td></tr><tr><td style="width: 13.9837%;" width="96"><p>&nbsp;</p><p>&nbsp;</p><p><strong>WHITE</strong></p><p>(Translucent)</p></td><td style="width: 30.0813%;" width="210"><p>&nbsp;</p><p>&nbsp;</p><p>Waste sharp including metals</p></td><td style="width: 24.878%;" width="174"><p>&nbsp;</p><p>Puncture proof, leak proof, Tamper proof container</p></td><td style="width: 30.8943%;" width="216"><p>Autoclaving/ Dry heat</p><p>THEN</p><p>Shredding / Mutilation/ Encapsulation</p><p>THEN</p><p>Iron foundries / Sanitary landfill / Waste sharp pit</p></td></tr><tr><td style="width: 13.9837%;" width="96"><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;Blue</strong></p></td><td style="width: 30.0813%;" width="210"><p>&nbsp;</p><p>Glassware</p><p>Metallic Body Implants</p></td><td style="width: 24.878%;" width="174"><p>Cardboard boxes with blue colored marking</p></td><td style="width: 30.8943%;" width="216"><p>Sodium hypochlorite/ Autoclaving/ Microwaving/ Hydroclaving</p><p>THEN</p><p>Recycling</p></td></tr></tbody></table></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 26</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A fluid that causes shifting of fluid from cells to blood:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hypertonic</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hypotonic</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Isotonic</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Isotope</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>A <strong>hypertonic</strong> solution has a higher concentration of solutes compared to the inside of the cells. When a hypertonic solution is introduced into the body, it causes water to move out of the cells (where the concentration of solutes is lower) into the bloodstream (where the concentration of solutes is higher), leading to cell shrinkage.</li>
</ul>
<ul>
<li><strong>Hypotonic:</strong> A hypotonic solution has a lower concentration of solutes than the inside of the cells. It causes water to move into the cells, potentially leading to cell swelling or bursting.</li>
<li><strong>Isotonic:</strong> An isotonic solution has the same concentration of solutes as inside the cells. It doesn't cause any significant movement of water in or out of the cells, as the concentration is balanced.</li>
<li><strong>Isotope:</strong> An isotope is a variant of a chemical element, not related to fluid balance or movement in the body.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 27</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Signs of fluid overload:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Elevated JVP</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Collapsed Jugular vein</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Thready pulse</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Irregular pulse</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Signs of fluid overload includes elevated JVP as a raised JVP indicates the presence of&nbsp;<strong>venous hypertension. </strong>Other signs of fluid overload include:
<ul>
<li>Peripheral edema</li>
<li>Displaced PMI (cardiomegaly)</li>
<li>S3</li>
<li>Pulmonary crackles</li>
<li>Hepatomegaly (passive liver congestion)</li>
<li>Hepatojugular reflux</li>
</ul>
</li>
<li>Other options are incorrect as they are seen in case of fluid depletion.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 28</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>An alcoholic patient is given disulfiram. This dose can cause DRE for how many days? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>96 hours</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 week</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>36 hours</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>24 hours</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Disulfiram is a medication used to help individuals with alcohol dependence avoid drinking by causing unpleasant reactions when alcohol is consumed. The reaction is called <strong>disulfiram-alcohol reaction (DAR)</strong>, which includes symptoms like nausea, vomiting, flushing, and headache.</li>
<li>When taken, disulfiram can cause these reactions for up to <strong>36 hours</strong> after alcohol consumption. The duration of the reaction can vary based on the individual's metabolism and the dose of disulfiram taken.</li>
<li>So, the <strong>36-hours</strong> timeframe is typically the period during which symptoms of the disulfiram-alcohol reaction are most likely to occur.&nbsp;&nbsp;</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 29</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Covishield vaccine is contraindicated in:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Previous allergy to first dose of Covishield</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>History of carcinoma</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>History of pollen allergy</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>History of radiation therapy</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Covishield (the AstraZeneca COVID-19 vaccine) is contraindicated in individuals who have had a <strong>severe allergic reaction</strong> (anaphylaxis) to the first dose of Covishield or any of its components. In such cases, it is advised not to administer the second dose due to the risk of an allergic reaction.</li>
</ul>
<p>Here's why the other options are not contraindications:</p>
<ul>
<li><strong>History of carcinoma:</strong> There is no specific contraindication to the Covishield vaccine for individuals with a history of carcinoma (cancer), unless they have an active allergy or other contraindications.</li>
<li><strong>History of pollen allergy:</strong> Pollen allergy is not a contraindication for the Covishield vaccine. Most people with seasonal allergies can receive the vaccine safely.</li>
<li><strong>History of radiation therapy:</strong> A history of radiation therapy does not specifically contraindicate the Covishield vaccine. However, individuals undergoing active cancer treatment or with a weakened immune system should consult their healthcare provider before getting the vaccine. &nbsp;</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 30</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Bluish discoloration of vagina and cervix in the first trimester is known as:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chadwick</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Osiander&rsquo;s</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hegar</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Goodell</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Table:</strong> Sign&rsquo;s in Pregnancy</p>
<table style="border-collapse: collapse; width: 88.6894%; height: 815px;" border="1">
<tbody>
<tr>
<td style="width: 100%;" colspan="2" width="763">
<p><strong>&nbsp;</strong></p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Chadwick sign</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>In early pregnancy, increased vascularity <strong>within the cervix</strong> stroma beneath the epithelium creates an ectocervical <strong>blue tint</strong> that is called Chadwick sign.</p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Goodell Sign</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>Cervical edema leads to <strong>softening of the cervix</strong>. The cervix contains more of fibrous tissue and collagen than the muscle</p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Hegar&rsquo;s sign</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>Isthmic softening of cervix</p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Ladin&rsquo;s sign</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>Softening in the midline of the uterus anteriorly at the junction of the uterus and cervix</p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Chloasma</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>Blotchy pigmentation is found in the nose and face</p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Linea nigra</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>Pigmentation is more commonly seen in lower abdominal midline area from the pubis to the umbilicus.</p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Striae gravidarum</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>In genetically predisposed women &ldquo;Stretch marks&rdquo; develop on the abdomen and buttocks</p>
</td>
</tr>
<tr>
<td style="width: 29.1367%;" width="193">
<p>Spider angiomata and palmer erythema</p>
</td>
<td style="width: 70.8633%;" width="570">
<p>Skin vascularity increases</p>
</td>
</tr>
</tbody>
</table>
<p><img title="image019.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/8b643341-96df-459d-b807-99fe2dfde04a.jpg" alt="" width="403" height="594" /></p>
<p><img title="image022.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/de33d73d-9f22-4f0d-b691-41318d7f4171.jpg" alt="" width="491" height="376" /></p>
<p><strong>Figure: Signs in Pregnancy</strong></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 31</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which preservative is used during packing of catgut?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Formaldehyde</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Glutaraldehyde</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Isopropyl alcohol</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Sodium hypochlorite</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>Isopropyl alcohol</strong> is the preservative commonly used for packing <strong>catgut sutures</strong>. Catgut is made from the natural fibers of animal intestines (usually sheep or goats) and is prone to degradation and bacterial contamination. Isopropyl alcohol is used to sterilize and preserve the sutures, ensuring they remain safe and effective for use during surgeries. It helps prevent microbial growth and maintains the integrity of the sutures while they are being stored.</li>
</ul>
<ul>
<li><strong>Formaldehyde:</strong> <strong>Formaldehyde</strong> is a strong preservative and disinfectant, but it is not typically used in the preservation of <strong>catgut</strong> sutures. It is more commonly used in other contexts, such as in the preservation of biological specimens, but not specifically for catgut sutures.</li>
<li><strong>Glutaraldehyde:</strong> <strong>Glutaraldehyde</strong> is also a powerful disinfectant and sterilizing agent, often used in medical and laboratory settings for sterilizing equipment. However, it is not the preservative used for catgut sutures. Its primary use is in disinfecting and sterilizing instruments, not sutures.</li>
<li><strong>Sodium hypochlorite:</strong> <strong>Sodium hypochlorite</strong>, also known as bleach, is a strong disinfectant used to clean surfaces and disinfect instruments, but it is not used for preserving catgut sutures. It is too harsh for preserving organic materials like sutures and can degrade them rather than preserve them.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 32</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong><strong>A patient comes with the diagnosis of COPD. What is the method of oxygen administration in this patient?</strong></strong></p>
<ol>
<li>Use Venturi mask at 28% (not more than 6 lit/ min)</li>
<li>Used the nasal cannula not more than 4 lit/ min</li>
<li>Maintain the SPO<sub>2</sub> in between 78 to 89%</li>
<li>Oxygen administration should not be more than 6 lit/ min</li>
</ol>
</body></html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>All are correct</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2, 3, 4 Correct</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Only 1 and 2</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1, 2 ,3 used</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li><strong>Use Venturi mask at 28% (not more than 6 liters/min):</strong> While the <strong>Venturi mask</strong> is useful for delivering a controlled and precise amount of oxygen, <strong>COPD</strong> patients generally require more cautious oxygen administration to avoid the risk of <strong>carbon dioxide retention</strong>. The Venturi mask provides fixed oxygen concentrations (like 28%, 40%, 60%), and a flow rate of <strong>not more than 6 liters/min</strong> is recommended. However, this may not be the most typical first choice for most COPD patients compared to other options.</li>
<li><strong>Use the nasal cannula not more than 4 liters/min: Nasal cannula</strong> is a common and safer method for oxygen delivery in COPD patients, especially when lower oxygen concentrations are required. Typically, oxygen should be administered at <strong>no more than 4 liters/min</strong>, as this allows for better control and avoids the risk of hyperoxia (too much oxygen) and carbon dioxide buildup. &nbsp;</li>
<li><strong>Maintain the SpO<sub>2</sub> between 78% to 89%:</strong> For COPD patients, <strong>targeting an oxygen saturation (SpO<sub>2</sub>)</strong> range of <strong>78% to 89%</strong> is crucial. Higher oxygen levels can suppress the patient's respiratory drive and cause carbon dioxide retention, leading to worsening hypercapnia (high CO<sub>2</sub> levels in the blood). &nbsp;</li>
<li><strong>Oxygen administration should not be more than 6 liters/min:</strong> This is a general recommendation to avoid excessive oxygen therapy. Higher oxygen levels can suppress the body&rsquo;s natural drive to breathe, especially in COPD patients, and may lead to the accumulation of carbon dioxide in the blood.</li>
</ul>
<ul>
<li><strong>All are correct:</strong> While most statements are generally correct, the first option about using the <strong>Venturi mask</strong> is not necessarily the first line of treatment in all COPD cases compared to the nasal cannula.</li>
<li><strong>Only 1 and 2:</strong> While the nasal cannula and controlled oxygen levels are correct, the <strong>SpO<sub>2</sub></strong> range of <strong>78-89%</strong> (point 3) is crucial for effective management and is missing in this option.</li>
<li><strong>Option 1, 2 and 3:</strong> This option is close, but the <strong>Venturi mask</strong> (point 1) is not always the first line, and so this combination isn't fully accurate.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 33</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Positive Stallworthy sign is seen in which of the following conditions? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Abruptio Placenta</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Placenta Previa</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Placenta Succenturiata</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Placenta Bilobata</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Stallworthy's sign, where the fetal heart rate slows down and soon recovers promptly on pressing the head down into the pelvis. This is more evident with posterior placenta previa.</li>
<li>The most common symptom of placenta previa is painless bleeding from the vagina during the second half of pregnancy.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 34</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Intramuscular injection is given at which angle? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>30 degree</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>60 degree</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>90 degree</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>15 degree</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Intramuscular (IM) administration is by injection into the striated muscle. The sites most commonly used for IM injection are the deltoid, dorsogluteal, rectus femoris, vastus lateralis and ventrogluteal muscles. The choice of a site depends on the volume to be injected.</li>
<li>90-degree angle of needle insertion for intramuscular injection as being that most effective in terms of patient comfort, safety and efficacy of vaccine.</li>
<li>Subcutaneous injections are usually given at a 45- to 90-degree angle. The angle is based on the amount of subcutaneous tissue present. Generally, give shorter needles at a 90-degree angle and longer needles at a 45-degree angle.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 35</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following muscles is the site for 2<sup>nd</sup> booster dose of DPT?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ventrogluteal</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vastus lateralis</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Deltoid</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Dorsogluteal</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Diphtheria-Tetanus-Pertussis Vaccine (DTP)</strong></p>
<ul>
<li><strong>Indications:</strong> Prevention of diphtheria, tetanus and pertussis in children under 7 years (primary vaccination and booster dose)</li>
<li><strong>Composition, forms, route of administration: </strong></li>
<li>Trivalent vaccine combining diphtheria toxin, tetanus toxin and whole-cell (DTwP) or acellular (DTaP) pertussis vaccine.</li>
<li>Suspension for injection in multidose vial, for IM injection into the anterolateral part of the thigh in children &lt; 2 years and in the deltoid muscle in children &ge; 2 years. Do not administer into the gluteal muscle.</li>
</ul>
<p><strong>Table: National Immunization Schedule-India </strong></p>
<table style="border-collapse: collapse; width: 93.7163%; height: 3117px;" border="1">
<tbody>
<tr>
<td style="width: 99.8967%;" colspan="10" width="707">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;For Infants </strong></p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p><strong>Vaccine </strong></p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p><strong>When to Give </strong></p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p><strong>Dose </strong></p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p><strong>Route </strong></p>
</td>
<td style="width: 18.3453%;" width="137">
<p><strong>Site </strong></p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>BCG</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>At birth or as early as possible until one year of age</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>0.1 mL (0.05 mL until 1 month of age)</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Intra-dermal</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Left upper arm</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>Hepatitis B- Birth Dose</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>At birth or as early as possible within 24 hours</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>0.5 mL</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Intra-muscular</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Antero-lateral side of mid-thigh</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>OPV-0</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>At birth or as early possible within the first 15 days</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>&nbsp;2 drops</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Oral</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>OPV-1, 2 and 3</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>At 6 weeks, 10 weeks and 14 weeks (OPV can be given until 5 years of age)</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>&nbsp;2 drops</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Oral</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>Pentavalent-1, 2 and 3</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>At 6 weeks, 10 weeks and 14 weeks (OPV can be given until 1 year of age)</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>0.5 mL</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Intra-muscular</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Antero-lateral side of mid-thigh</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>Rotavirus</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>At 6 weeks, 10 weeks and 14 weeks (OPV can be given until 1 year of age)</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>5 drops</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Oral</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>IPV</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>Two fractional disease at 6 and 14 weeks of age</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>0.1 mL</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Intra-dermal 2 fractional doses</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Intradermal-Right upper arm</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>PCV (Wherever applicable)</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>At 6 weeks and 14 weeks; Booster at 9 completed months</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>0.5 mL</p>
</td>
<td style="width: 32.0944%;" colspan="3" width="143">
<p>Intra-muscular</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Antero-lateral side of mid-thigh</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>Measles/MR 1<sup>st</sup> Dose</p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>9 completed months - 12 months (Can be given till 5 years of age)</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>0.5 mL</p>
</td>
<td style="width: 30.2598%;" colspan="2" width="142">
<p>Subcutaneous</p>
</td>
<td style="width: 20.1799%;" colspan="2" width="138">
<p>Right upper arm</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>JE-1<strong>*</strong></p>
</td>
<td style="width: 16.5468%;" colspan="2" width="179">
<p>9 completed months - 12 months</p>
</td>
<td style="width: 14.1326%;" colspan="2" width="125">
<p>0.5 mL</p>
</td>
<td style="width: 30.2598%;" colspan="2" width="142">
<p>Subcutaneous</p>
</td>
<td style="width: 20.1799%;" colspan="2" width="138">
<p>Left upper arm</p>
</td>
</tr>
<tr>
<td style="width: 18.7776%;" colspan="2" width="123">
<p>Vitamin A (1<sup>st</sup> Dose)</p>
</td>
<td style="width: 16.5468%;" width="179">
<p>At 9 completed months with measles Rubella</p>
</td>
<td style="width: 14.1326%;" colspan="3" width="125">
<p>1 mL (1 lakh IU)</p>
</td>
<td style="width: 30.2598%;" colspan="2" width="142">
<p>Oral</p>
</td>
<td style="width: 20.1799%;" colspan="2" width="138">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 99.8967%;" colspan="10" width="707">
<p><strong>&nbsp;&nbsp;&nbsp;&nbsp;For Children </strong></p>
</td>
</tr>
<tr>
<td style="width: 18.5252%;" width="122">
<p>DPT Booster-1</p>
</td>
<td style="width: 23.6664%;" colspan="4" width="183">
<p>16 - 24 months</p>
</td>
<td style="width: 18.3517%;" colspan="2" width="130">
<p>0.5 mL</p>
</td>
<td style="width: 21.0082%;" colspan="2" width="135">
<p>Intra-muscular</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Antero-lateral side of mid-thigh</p>
</td>
</tr>
<tr>
<td style="width: 18.5252%;" width="122">
<p>Measles/MR 2<sup>nd</sup> Dose</p>
</td>
<td style="width: 23.6664%;" colspan="4" width="183">
<p>16 - 24 months</p>
</td>
<td style="width: 18.3517%;" colspan="2" width="130">
<p>0.5 mL</p>
</td>
<td style="width: 21.0082%;" colspan="2" width="135">
<p>Subcutaneous</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Right upper arm</p>
</td>
</tr>
<tr>
<td style="width: 18.5252%;" width="122">
<p>OPV-Booster</p>
</td>
<td style="width: 23.6664%;" colspan="4" width="183">
<p>16 - 24 months</p>
</td>
<td style="width: 18.3517%;" colspan="2" width="130">
<p>2 drops</p>
</td>
<td style="width: 21.0082%;" colspan="2" width="135">
<p>Oral</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 18.5252%;" width="122">
<p>JE-2</p>
</td>
<td style="width: 23.6664%;" colspan="4" width="183">
<p>16 - 24 months</p>
</td>
<td style="width: 18.3517%;" colspan="2" width="130">
<p>0.5 mL</p>
</td>
<td style="width: 21.0082%;" colspan="2" width="135">
<p>Subcutaneous</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Left upper arm</p>
</td>
</tr>
<tr>
<td style="width: 18.5252%;" width="122">
<p>Vitamin-A (2<sup>nd</sup> to 9<sup>th</sup> Dose) <strong>**</strong></p>
</td>
<td style="width: 23.6664%;" colspan="4" width="183">
<p>16 - 18 months</p>
<p>One dose every 6 months upto the age of 5 years</p>
</td>
<td style="width: 18.3517%;" colspan="2" width="130">
<p>2 mL (2 lakhs IU)</p>
</td>
<td style="width: 21.0082%;" colspan="2" width="135">
<p>Oral</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Oral</p>
</td>
</tr>
<tr>
<td style="width: 18.5252%;" width="122">
<p>DPT Booster-2</p>
</td>
<td style="width: 23.6664%;" colspan="4" width="183">
<p>5 - 6 years</p>
</td>
<td style="width: 18.3517%;" colspan="2" width="130">
<p>0.5 mL</p>
</td>
<td style="width: 21.0082%;" colspan="2" width="135">
<p>Intra-muscular</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Upper arm</p>
</td>
</tr>
<tr>
<td style="width: 18.5252%;" width="122">
<p>Td</p>
</td>
<td style="width: 23.6664%;" colspan="4" width="183">
<p>10 years and 16 years</p>
</td>
<td style="width: 18.3517%;" colspan="2" width="130">
<p>0.5 mL</p>
</td>
<td style="width: 21.0082%;" colspan="2" width="135">
<p>Intra-muscular</p>
</td>
<td style="width: 18.3453%;" width="137">
<p>Upper arm</p>
</td>
</tr>
</tbody>
</table>
<p>*JE- vaccine is introduced in select endemic districts after the campaigns.</p>
<p>**The 2<sup>nd</sup> to 9<sup>th</sup> doses of vitamin A can be administered to children 1 - 5 years old during biannual rounds, in collaboration with ICDS.</p>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 36</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>SSPE is the complication of which of the following disease? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>EBV</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Measles</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Varicella</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Mumps</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Subacute sclerosing panencephalitis (SSPE)&mdash;also known as Dawson disease.</li>
<li>It is a rare form of chronic, progressive brain inflammation caused by slow infection with certain defective strains of <strong>hyper mutated measles virus</strong>.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 37</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is the most common cause of UTI in children? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><em>E. coli</em></p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Proteus</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><em>S. aureus</em></p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pneumococcus</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>A urinary tract infection is inflammation of part of the system that takes urine out of the body. It is caused by bacteria.</li>
<li>Most infections are caused by bacteria from the digestive tract. The most common is <em>Escherichia coli</em> (<em> coli</em>) bacteria.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 38</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is crowning? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Rotation at pelvic floor</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Largest skull diameter fixed that doesn&rsquo;t goes back</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Largest diameter at ischial spines</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>None of the above</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The encirclement of the largest head diameter by the vulval ring is called crowning. This occurs in the second stage of labor.</li>
<li><strong>Crowning</strong> refers to the stage during labor when the <strong>largest part of the baby's head</strong> (the widest diameter of the skull) becomes visible at the vaginal opening and does not retreat back into the birth canal with each contraction. It is considered the point when the baby's head is at the perineum and ready for delivery.</li>
<li><strong>Rotation at pelvic floor:</strong> This refers to the process of fetal head rotation as it descends through the birth canal, but it is not specifically "crowning." Rotation happens before crowning and allows the baby&rsquo;s head to align with the birth canal.</li>
<li><strong>Largest diameter at ischial spines:</strong> The <strong>ischial spines</strong> mark a point in the birth canal where the baby&rsquo;s head is engaging. However, this is not what is referred to as "crowning." Crowning is when the largest part of the skull is visible at the vaginal opening.</li>
<li><strong>None of the above:</strong> This is incorrect, as option <strong>b</strong> is the correct answer.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 39</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>All indicators are age independent, except:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Chest circumference</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>BMI</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Weight for height</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>MUAC</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Age Independent Anthropometry</strong></p>
<ul>
<li>Midarm Circumference (MAC)</li>
<li>Weight for Height</li>
<li>Quackstick</li>
<li>Midarm/Head Circumference ratio</li>
<li>Quetlet&rsquo;s Index</li>
<li>Mid-upper Arm/Height Ratio</li>
<li>Body Mass Index (BMI)</li>
<li>Ponderal Index (PI)</li>
</ul>
<p><strong>Interpretation of Indicators </strong></p>
<p><strong><img src="data:image/png;base64,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" /></strong></p>
<p><strong>Table 1: </strong>Degree of PEM</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 24.3902%;" width="186">
<p><strong>Degree of PEM </strong></p>
</td>
<td style="width: 35.3659%;" width="270">
<p><strong>Stunting (%) height for age </strong></p>
</td>
<td style="width: 40.0813%;" width="306">
<p><strong>Wasting (%) weight for height </strong></p>
</td>
</tr>
<tr>
<td style="width: 24.3902%;" width="186">
<p>Normal: Grade 0</p>
</td>
<td style="width: 35.3659%;" width="270">
<p>&nbsp;&gt; 95%</p>
</td>
<td style="width: 40.0813%;" width="306">
<p>&gt; 90</p>
</td>
</tr>
<tr>
<td style="width: 24.3902%;" width="186">
<p>Mild: Grade-I</p>
</td>
<td style="width: 35.3659%;" width="270">
<p>87.5 - 95</p>
</td>
<td style="width: 40.0813%;" width="306">
<p>80 - 90</p>
</td>
</tr>
<tr>
<td style="width: 24.3902%;" width="186">
<p>Moderate: Grade-II</p>
</td>
<td style="width: 35.3659%;" width="270">
<p>80 - 87.5</p>
</td>
<td style="width: 40.0813%;" width="306">
<p>70 - 80</p>
</td>
</tr>
<tr>
<td style="width: 24.3902%;" width="186">
<p>Severe: Grade-III</p>
</td>
<td style="width: 35.3659%;" width="270">
<p>&lt; 80</p>
</td>
<td style="width: 40.0813%;" width="306">
<p>&lt; 70</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Age independent Indices:</strong> Useful in situation where child&rsquo;s age is not known, e.g. children from orphanages, street children, during natural disasters, etc.</p>
<p><strong>Table 2: </strong>Diagnosis of Malnutrition</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 49.8201%;" width="353">
<p><strong>&nbsp;&nbsp;MAC</strong></p>
</td>
<td style="width: 50.1799%;" width="353">
<p><strong>&nbsp;Bangle test</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.8201%;" rowspan="3" width="353">
<p>&bull; It is the circumference of the left upper arm, measured at the mid-point between the tip of the shoulder and the tip of the elbow (Olecranon process and the acromium).</p>
<p>&bull; &nbsp;Normal value is 16 - 17 cm in age group of 1 - 5 years</p>
<p>&bull; &nbsp;&lt; 13.5: Borderline malnutrition</p>
<p>&bull; &nbsp;&lt; 11. 5: Severe acute malnutrition</p>
</td>
<td style="width: 50.1799%;" width="353">
<p>&bull; In case of malnutrition a bangle of 4 cm diameter passes above elbow</p>
</td>
</tr>
<tr>
<td style="width: 50.1799%;" width="353">
<p>&nbsp;<strong>Shakir tape method </strong></p>
</td>
</tr>
<tr>
<td style="width: 50.1799%;" width="353">
<p>&bull; &nbsp;This special tape has colored zones: red, yellow and green corresponding to &lt; 12.5 cm (wasted), 12.5 - 13.5 cm (borderline) and over 13. 5 cm (normal) MUAC respectively.</p>
<p>&nbsp;<img title="image016.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/bb13f3fd-689d-4965-9897-bb4a041474aa.jpg" alt="" width="261" height="160" /><strong>&nbsp;</strong></p>
<p><strong>Figure 1: Shakir tape</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.8201%;" width="353">
<p><strong>&nbsp;Skin fold thickness</strong></p>
</td>
<td style="width: 50.1799%;" width="353">
<p><strong>&nbsp;Ratios</strong></p>
</td>
</tr>
<tr>
<td style="width: 49.8201%;" width="353">
<p>&bull;&nbsp; It is an indicator of subcutaneous fat.</p>
<p>&bull;&nbsp; A skin fold thickness in triceps above 10 mm is normal and below 6 mm indicates malnutrition</p>
<p>&bull;&nbsp; It is measured using <strong>Harpenden caliper</strong>.</p>
<p>&nbsp;<img title="image018.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/53055b62-7683-49a0-9c59-4b507e55961b.jpg" alt="" width="223" height="125" /></p>
<p><strong>Figure 2: Harpenden caliper</strong></p>
</td>
<td style="width: 50.1799%;" width="353">
<p>&bull;&nbsp; Kanawati index</p>
<p>&bull; &nbsp;Dagdale&rsquo;s index</p>
<p>&bull; &nbsp;Quaker arm circumference</p>
<p>&bull; &nbsp;Jeliffe&rsquo;s ratio</p>
<p>&bull; &nbsp;Rao and Singh</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Table 3: Age Independent Anthropometric Indices</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 24.1007%;" width="162">
<p><strong>Name of index</strong></p>
</td>
<td style="width: 33.8129%;" width="270">
<p><strong>Calculation</strong></p>
</td>
<td style="width: 16.3669%;" width="138">
<p><strong>Normal value</strong></p>
</td>
<td style="width: 25.7194%;" width="216">
<p><strong>Value in malnutrition</strong></p>
</td>
</tr>
<tr>
<td style="width: 24.1007%;" width="162">
<p><strong>Kanawati and McLaren</strong></p>
</td>
<td style="width: 33.8129%;" width="270">
<p>Mid-arm circumference /head circumference (cm)</p>
</td>
<td style="width: 16.3669%;" width="138">
<p>0.32 - 0.33</p>
</td>
<td style="width: 25.7194%;" width="216">
<p>Severely malnourished &lt;0.25</p>
</td>
</tr>
<tr>
<td style="width: 24.1007%;" width="162">
<p><strong>Rao and Singh</strong></p>
</td>
<td style="width: 33.8129%;" width="270">
<p>Weight (in kg) x 100/height (in cm)</p>
</td>
<td style="width: 16.3669%;" width="138">
<p>0.14</p>
</td>
<td style="width: 25.7194%;" width="216">
<p>0.12 - 0.14</p>
</td>
</tr>
<tr>
<td style="width: 24.1007%;" width="162">
<p><strong>Dugdale</strong></p>
</td>
<td style="width: 33.8129%;" width="270">
<p>Weight (in kg)/height (in cm)</p>
</td>
<td style="width: 16.3669%;" width="138">
<p>0.88-0.97</p>
</td>
<td style="width: 25.7194%;" width="216">
<p>&lt;0.79</p>
</td>
</tr>
<tr>
<td style="width: 24.1007%;" width="162">
<p><strong>Quaker arm circumference measuring stick (Quack stick)</strong></p>
</td>
<td style="width: 33.8129%;" width="270">
<p>Mid-arm circumference (that would be expected for a given height)</p>
</td>
<td style="width: 16.3669%;" width="138">
<p>&nbsp;</p>
</td>
<td style="width: 25.7194%;" width="216">
<p>75 - 85% malnourished; &lt;75% severely malnourished</p>
</td>
</tr>
<tr>
<td style="width: 24.1007%;" width="162">
<p><strong>Jeliffe&rsquo;s ratio</strong></p>
</td>
<td style="width: 33.8129%;" width="270">
<p>Head circumference/chest circumference</p>
</td>
<td style="width: 16.3669%;" width="138">
<p>&nbsp;</p>
</td>
<td style="width: 25.7194%;" width="216">
<p>Ratio &lt;1 in a child &gt;1 year suggests malnutrition</p>
</td>
</tr>
</tbody>
</table></li></ul></div></div>
            <div class="question">
                <h3>Question No: 40</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Diseases that occur in 5 to 7 years of interval are</strong><strong> called:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Secular Trend</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Time trend</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Periodic trend</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cyclic trend</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Cyclic Trends: </strong></p>
<ul>
<li>It refers to occurrence of a disease/event in cycles spread over short period of time (i.e. days, week, month, year).</li>
<li>In case of infectious disease, it is due to build-up of susceptible in the &ldquo;herd&rdquo;.</li>
<li>Measles (every 2 - 3 years) in pre vaccination era, Rubella (every 6 - 9 years), influenza pandemics (7 - 10 years) due to antigenic variations.</li>
</ul>
<p><strong>Secular Trend: </strong></p>
<ul>
<li>Changes in occurrence of a disease (progressive increase or decrease) over a long period of time, generally several years or decades.</li>
<li>The consistent tendency to change in a particular direction or a definite movement in one direction.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 41</h3>
                <p><b>Which of the following best describes Covid 19?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Pandemic</li><li>2. Endemic</li><li>3. Epidemic</li><li>4. Sporadic</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>WHO classifies COVID-19 (Corona Virus) as a pandemic on 11th March 2020. </li><li><b>Pandemic:</b> When a disease usually spreads to global level or when it crosses two WHO regions or two continents. E.g. Influenza, HIV and AIDS, SARS and COVID-10.</li><li><b>Endemic:</b> Constant presence of the disease among population, which is epidemiologically linked in time, person or (usually) place. E.g. Hepatitis, malaria, dengue and diarrhea. </li><li><b>Epidemic:</b> A rise (usually sudden) in numbers of cases which is clearly in excess and which is more than 80% of expected frequency or greater than 2 standard deviation. E.g. For any disease. </li><li><b>Sporadic:</b> Scattered cases. Not epidemiologically linked in terms of time place or person. E.g. Polio, Tetanus, herpes zoster and rabies. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 42</h3>
                <p><b>Which of the following is not a symptom of multisystem involvement in Covid-19? </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Fever</li><li>2. Rash</li><li>3. Pruritic conjunctivitis</li><li>4. Shock</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>A rash on skin, or discoloration of fingers or toes and red or irritated eyes are less common symptoms COVID-19. Among them pruritic con junctivitis, a potential albeit uncommon symptom of the coronavirus pandemic. So that will be the correct answer.</li><li>Shock has been implicated as the primary cause of death in 7% of coronavirus disease 2019 (COVID-19) cases and as a contributing factor in an additional 33%. All 4 types of shock&mdash; distributive, cardiogenic, obstructive and hypovolemic shock&mdash;have been observed in patients with COVID-19.</li><li>Fever is most common symptom of COVID-19.</li></ul></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 43</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is not included in surgical safety checklist? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Before induction of anesthesia</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Before skin incision</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>After skin incision</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Before leaving the operative room</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The checklist divides the operation into three phases, each corresponding to a specific time period in the normal flow of a procedure &mdash; the period before induction of anesthesia <strong>(Sign In),</strong> the period after induction and before surgical <strong>incision (Time Out) and</strong> the period during or immediately after wound closure but before removing the patient from the operating room <strong>(Sign Out). &nbsp;</strong></li>
<li>In each phase, the checklist coordinator must be permitted to confirm that the team has completed its tasks before it proceeds further. As operating teams become familiar with the steps of the checklist, they can integrate the checks into their familiar work patterns and verbalize their completion of each step without the explicit intervention of the checklist coordinator. &nbsp;&nbsp;</li>
<li>Each team should seek to incorporate use of the checklist into its work with maximum efficiency and minimum disruption, while aiming to accomplish the steps effectively.</li>
</ul>
<p><strong>Table: Surgical Checklist &nbsp;&nbsp;&nbsp;</strong></p>
<p><img title="image029.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/7b66bc9f-6b7d-4bde-83cb-f20d9a008df3.jpg" alt="" width="262" height="417" /></p>
<p><img title="image031.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/673b2ba3-f06d-4448-acd0-8fc911f6d8f4.jpg" alt="" width="425" height="364" /></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 44</h3>
                <p><b>Which of the following foods contain high dietary fiber? </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Orange</li><li>2. Wheat</li><li>3. Spinach</li><li>4. Green gram</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Spinach is high in insoluble fiber, which may boost your health in several ways. </li><li>It adds bulk to stool as food passes through your digestive system. This may help prevent constipation.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 45</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Caudal regression syndrome is seen in:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Gestational HTN</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Gestational diabetes</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Eclampsia</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>None of the above</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Caudal regression syndrome is a rare congenital malformation with varying degrees of early gestational developmental failure. It is also known as sacral agenesis or caudal dysplasia. The cause of this malformation is thought to be defects in neuralization around the 28th day of the gestational period.</li>
<li>Caudal regression syndrome is estimated to occur in 1 to 2.5 per 100,000 newborns. This condition is much more common in infants born to mothers with diabetes when it affects an estimated 1 in 350 newborns.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 46</h3>
                <p><b>A female reported with excessive vomiting and diagnosis of complete mole. Which of the following is true about complete mole? </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Decrease HCG level</li><li>2. It will be triploid</li><li>3. The genotype will be 46(xx)</li><li>4. Height of uterus less than gestational age</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><p><strong>Table:</strong> Features of complete and partial mole</p><table style="border-collapse: collapse; width: 100%;" border="1"><tbody><tr><td style="width: 23.0081%;" width="174"><p><strong>Features</strong></p></td><td style="width: 35.6911%;" width="270"><p><strong>Complete Mole</strong></p></td><td style="width: 41.2195%;" width="312"><p><strong>Partial Mole</strong></p></td></tr><tr><td style="width: 23.0081%;" width="174"><p>Fetus</p></td><td style="width: 35.6911%;" width="270"><p>Absent</p></td><td style="width: 41.2195%;" width="312"><p>Present, malformed or IUGR</p></td></tr><tr><td style="width: 23.0081%;" width="174"><p>Fetal vessels</p></td><td style="width: 35.6911%;" width="270"><p>Absent</p></td><td style="width: 41.2195%;" width="312"><p>Present</p></td></tr><tr><td style="width: 23.0081%;" width="174"><p>Hydropic changes</p></td><td style="width: 35.6911%;" width="270"><p>Diffuse and placenta not present</p></td><td style="width: 41.2195%;" width="312"><p>Focal</p></td></tr><tr><td style="width: 23.0081%;" width="174"><p>Trophoblastic hyperplasia</p></td><td style="width: 35.6911%;" width="270"><p>Marked</p></td><td style="width: 41.2195%;" width="312"><p>Mild to moderate</p></td></tr><tr><td style="width: 23.0081%;" width="174"><p>&beta;-hCG level</p></td><td style="width: 35.6911%;" width="270"><p>Very high</p></td><td style="width: 41.2195%;" width="312"><p>Comparatively low</p></td></tr><tr><td style="width: 23.0081%;" width="174"><p>Karyotype</p></td><td style="width: 35.6911%;" width="270"><p>46 XX mostly and paternally derived</p></td><td style="width: 41.2195%;" width="312"><p>69 XXY</p></td></tr><tr><td style="width: 23.0081%;" width="174"><p>Malignant potential</p></td><td style="width: 35.6911%;" width="270"><p>15 &ndash; 20%</p></td><td style="width: 41.2195%;" width="312"><p>Rare</p></td></tr></tbody></table></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 47</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is not a feature of pre- eclampsia? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hypertension</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Proteinuria</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Polyuria</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hypotension</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Table 1:</strong> Classification and Diagnosis of Pregnancy-Associated Hypertension</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 25.0407%;" width="187">
<p><strong>&nbsp;Condition </strong></p>
</td>
<td style="width: 74.7967%;" colspan="2" width="558">
<p><strong>&nbsp;Criteria required </strong></p>
</td>
</tr>
<tr>
<td style="width: 25.0407%;" width="187">
<p>Gestational hypertension</p>
</td>
<td style="width: 74.7967%;" colspan="2" width="558">
<p>BP &gt; 140/90 mm Hg after 20 weeks in previously normotensive women.</p>
</td>
</tr>
<tr>
<td style="width: 25.0407%;" rowspan="7" width="187">
<p>Preeclampsia: Hypertension plus</p>
</td>
<td style="width: 28.1301%;" width="210">
<p>Proteinuria</p>
</td>
<td style="width: 46.6667%;" width="348">
<ul>
<li>&ge;300 mg/24 h, or</li>
<li>Urine protein: creatinine ratio 20.3, or</li>
<li>Dipstick 1 + persistent</li>
</ul>
</td>
</tr>
<tr>
<td style="width: 74.7967%;" colspan="2" width="558">
<p>&nbsp;&nbsp; <strong>Or </strong></p>
</td>
</tr>
<tr>
<td style="width: 28.1301%;" width="210">
<p>Thrombocytopenia</p>
</td>
<td style="width: 46.6667%;" width="348">
<p>Platelet count &lt; 100,000/&micro;L</p>
</td>
</tr>
<tr>
<td style="width: 28.1301%;" width="210">
<p>Renal insufficiency</p>
</td>
<td style="width: 46.6667%;" width="348">
<p>Creatinine level &gt; 1.1 mg/dL or doubling of baseline</p>
</td>
</tr>
<tr>
<td style="width: 28.1301%;" width="210">
<p>Liver involvement</p>
</td>
<td style="width: 46.6667%;" width="348">
<p>Serum transaminase levels twice normal</p>
</td>
</tr>
<tr>
<td style="width: 28.1301%;" width="210">
<p>Cerebral symptoms</p>
</td>
<td style="width: 46.6667%;" width="348">
<p>Headache, visual disturbances, convulsions</p>
</td>
</tr>
<tr>
<td style="width: 28.1301%;" width="210">
<p>Pulmonary edema</p>
</td>
<td style="width: 46.6667%;" width="348">
<p>&nbsp;--------</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Table 2:</strong> Preeclampsia&ndash;Eclampsia Spectrum</p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 20.5691%;" width="157">
<p>&nbsp;</p>
</td>
<td style="width: 27.4797%;" width="210">
<p><strong>Preeclampsia without Severe Features</strong></p>
</td>
<td style="width: 25.122%;" width="192">
<p><strong>Preeclampsia with Severe Features</strong></p>
</td>
<td style="width: 26.748%;" width="204">
<p><strong>Eclampsia</strong></p>
</td>
</tr>
<tr>
<td style="width: 20.5691%;" width="157">
<p><strong>Symptoms</strong></p>
</td>
<td style="width: 27.4797%;" width="210">
<p>&nbsp;Not seen</p>
</td>
<td style="width: 25.122%;" width="192">
<p>Pain in the epigastric area or right upper quadrant; or Headache or visual disturbances</p>
</td>
<td style="width: 26.748%;" width="204">
<p>Patients have unexplained convulsions.</p>
</td>
</tr>
<tr>
<td style="width: 20.5691%;" width="157">
<p><strong>Other findings</strong></p>
</td>
<td style="width: 27.4797%;" width="210">
<p>&nbsp;Not seen</p>
</td>
<td style="width: 25.122%;" width="192">
<p>Pulmonary edema or cyanosis</p>
</td>
<td style="width: 26.748%;" width="204">
<p>May or may not be present any symptoms in patients</p>
</td>
</tr>
<tr>
<td style="width: 20.5691%;" width="157">
<p><strong>Laboratory tests</strong></p>
</td>
<td style="width: 27.4797%;" width="210">
<ul>
<li>Proteinuria, with excretion of 0.3 g or more of protein in a 24-hour urine specimen.</li>
<li>DIC is not found.</li>
<li>Liver function tests remains normal</li>
</ul>
</td>
<td style="width: 25.122%;" width="192">
<ul>
<li>Proteinuria, with excretion of 5 g or 3+ more of protein in a 24-hour urine specimen.</li>
<li>Impairment of liver function</li>
</ul>
</td>
<td style="width: 26.748%;" width="204">
<p>Proteinuria, with excretion of 1 - 2+ of protein in a 24-hour urine specimen.</p>
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 20.5691%;" width="157">
<p><strong>Sustained&uarr; blood pressure</strong></p>
</td>
<td style="width: 27.4797%;" width="210">
<ul>
<li>The blood pressure sustained in between &gt;140/90 mm Hg to</li>
<li>&lt;160/110 mm Hg</li>
</ul>
</td>
<td style="width: 25.122%;" width="192">
<ul>
<li>At least &gt;140/90 (if other findings) or</li>
<li>&gt;160/110 mm Hg; six or more hours apart in a pregnant woman who is on bed rest</li>
</ul>
</td>
<td style="width: 26.748%;" width="204">
<p>At least blood pressure &gt;140/90 mm Hg</p>
</td>
</tr>
<tr>
<td style="width: 20.5691%;" width="157">
<p><strong>Management</strong></p>
</td>
<td style="width: 27.4797%;" width="210">
<ul>
<li>If &lt;36 weeks: observe in hospital, no medication like MgSO<sub>4</sub>, or blood pressure medication,</li>
<li>If &gt;36 weeks: try to prompt delivery</li>
</ul>
</td>
<td style="width: 51.87%;" colspan="2" width="396">
<ul>
<li>Medication to prevent or treat convulsions: MgSO<sub>4</sub></li>
<li>Lower diastolic, BP to 90 &ndash; 100 mm Hg</li>
<li>Try to prompt the delivery at 34 weeks, but not necessarily Cesarean section</li>
</ul>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 48</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A patient has a respiratory rate of 36/min, this condition is known as: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Eupnea</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Dyspnea</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bradypnea</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Tachypnea</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Tachypnea is defined as a breathing rate that is higher than the normal breathing rate. This condition is seen in both the physiologic state as well as a symptom of pathology.</li>
<li>The normal respiration rate for an adult at rest is 12 to 20 breaths per minute. A respiration rate under 12 or over 25 breaths per minute while resting is considered abnormal.</li>
<li>Eupnea: normal relaxed breathing.</li>
<li>Dyspnea also called shortness of breath, is a tight feeling in your chest where you may not be able to take a deep breath. This is a symptom that can be linked to many different conditions, like asthma, heart failure and lung disease.</li>
<li>Bradypnea: Abnormally slow breathing. A respiratory rate that is too slow. The normal rate of respirations (breaths per minute) depends on a number of factors, including the age of the individual and the degree of exertion.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 49</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What will be prescribed to the mother to prevent neural tube defect (NTD) in fetus? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>B<sub>6</sub></p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>B<sub>12</sub></p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>B<sub>2</sub></p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Folic acid</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Supplements of folate given inappropriate dose before conception can result in a significant reduction in the incidence of spina bifidia and other neural tube defect.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 50</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A patient of RTA with head injury comes to the hospital. You assess the patient by using GCS and the patient score is 9. What is the range of GCS? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>15 and 5</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10 and 0</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>15 and 3</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>15 and 0</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p><strong>Glasgow coma scale (GCS)</strong></p>
<ul>
<li>The Glasgow Coma Scale (GCS) is the most common scoring system used to describe the <strong>level of consciousness</strong> in a person following a <strong>traumatic brain injury</strong>. Basically, it is used to measure the severity of an <strong>acute brain injury</strong>.</li>
<li>The Glasgow Coma Scale was first published in 1974 at the University of Glasgow by neurosurgery professors Graham Teasdale and Bryan Jennett.</li>
<li>Three parameters are used- <strong>eye opening, verbal response and best motor response</strong> with the score <strong>ranging from 3 - 15</strong>.</li>
<li>Three parameters are assessed:
<ul>
<li><strong>Eye opening (E):</strong> Used as a reflection of the intensity of impairment of activating functions.</li>
<li><strong>Verbal response (V):</strong> Index of higher cortical function.</li>
<li><strong>Best motor response (M):</strong> Knowing the integrity of the nervous system in patients who are not speaking.</li>
</ul>
</li>
<li>The Glasgow Coma Scale (GCS) estimates coma severity based on Eye (4), Verbal (5) and Motor (6) criteria.</li>
<li>The Normal Glasgow Coma Scale (GCS) written as E<sub>4</sub>V<sub>5</sub>M<sub>6</sub>.</li>
</ul>
<p><strong>Table 1: Glasgow Coma Scale &nbsp;</strong></p>
<table style="border-collapse: collapse; width: 100.724%; height: 662px;" border="1">
<tbody>
<tr style="height: 54.3906px;">
<td style="width: 37.246%; height: 54.3906px;" colspan="4" width="218">
<p><strong>&nbsp;Eyes open</strong></p>
</td>
<td style="width: 25.6579%; height: 54.3906px;" colspan="3" width="250">
<p><strong>&nbsp;Verbal</strong></p>
</td>
<td style="width: 37.04%; height: 54.3906px;" colspan="3" width="282">
<p><strong>&nbsp;Motor</strong></p>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 21.7985%; height: 54.3906px;" colspan="2" width="154">
<p><strong>&nbsp;Response</strong></p>
</td>
<td style="width: 15.4475%; height: 54.3906px;" colspan="2" width="63">
<p><strong>Score</strong></p>
</td>
<td style="width: 15.3211%; height: 54.3906px;" colspan="2" width="172">
<p><strong>&nbsp;Response</strong></p>
</td>
<td style="width: 10.3368%; height: 54.3906px;" width="78">
<p><strong>&nbsp;Scor</strong><strong>e</strong></p>
</td>
<td style="width: 27.5647%; height: 54.3906px;" colspan="2" width="191">
<p><strong>&nbsp;Response</strong></p>
</td>
<td style="width: 9.47536%; height: 54.3906px;" width="91">
<p><strong>Score</strong></p>
</td>
</tr>
<tr style="height: 99.1719px;">
<td style="width: 21.5349%; height: 99.1719px;" width="154">
<p><strong>Spontaneously</strong></p>
</td>
<td style="width: 6.24731%; height: 99.1719px;" colspan="2" width="63">
<p><strong>&nbsp;4</strong></p>
</td>
<td style="width: 24.6961%; height: 99.1719px;" colspan="2" width="172">
<p><strong>Normal oriented conversation</strong></p>
</td>
<td style="width: 10.4255%; height: 99.1719px;" colspan="2" width="79">
<p><strong>&nbsp;5</strong></p>
</td>
<td style="width: 27.5647%; height: 99.1719px;" width="191">
<p><strong>Obeys commands</strong></p>
</td>
<td style="width: 9.47536%; height: 99.1719px;" colspan="2" width="91">
<p><strong>&nbsp;6</strong></p>
</td>
</tr>
<tr style="height: 76.7812px;">
<td style="width: 21.5349%; height: 76.7812px;" width="154">
<p><strong>To verbal command</strong></p>
</td>
<td style="width: 6.24731%; height: 76.7812px;" colspan="2" width="63">
<p><strong>&nbsp;3</strong></p>
</td>
<td style="width: 24.6961%; height: 76.7812px;" colspan="2" width="172">
<p><strong>Confused</strong></p>
</td>
<td style="width: 10.4255%; height: 76.7812px;" colspan="2" width="79">
<p><strong>&nbsp;4</strong></p>
</td>
<td style="width: 27.5647%; height: 76.7812px;" width="191">
<p><strong>&nbsp;Localizes to pain</strong></p>
</td>
<td style="width: 9.47536%; height: 76.7812px;" colspan="2" width="91">
<p><strong>&nbsp;5</strong></p>
</td>
</tr>
<tr style="height: 92.7812px;">
<td style="width: 21.5349%; height: 92.7812px;" width="154">
<p><strong>To painful stimulus</strong></p>
</td>
<td style="width: 6.24731%; height: 92.7812px;" colspan="2" width="63">
<p><strong>&nbsp;2</strong></p>
</td>
<td style="width: 24.6961%; height: 92.7812px;" colspan="2" width="172">
<p><strong>Inappropriate/</strong></p>
<p><strong>words only</strong></p>
</td>
<td style="width: 10.4255%; height: 92.7812px;" colspan="2" width="79">
<p><strong>&nbsp;3</strong></p>
</td>
<td style="width: 27.5647%; height: 92.7812px;" width="191">
<p><strong>Withdrawal/flexion</strong></p>
</td>
<td style="width: 9.47536%; height: 92.7812px;" colspan="2" width="91">
<p><strong>&nbsp;4</strong></p>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 21.5349%; height: 54.3906px;" width="154">
<p><strong>Do not open</strong></p>
</td>
<td style="width: 6.24731%; height: 54.3906px;" colspan="2" width="63">
<p><strong>&nbsp;1</strong></p>
</td>
<td style="width: 24.6961%; height: 54.3906px;" colspan="2" width="172">
<p><strong>Sounds only</strong></p>
</td>
<td style="width: 10.4255%; height: 54.3906px;" colspan="2" width="79">
<p><strong>&nbsp;2</strong></p>
</td>
<td style="width: 27.5647%; height: 54.3906px;" width="191">
<p><strong>&nbsp;Abnormal flexion</strong></p>
</td>
<td style="width: 9.47536%; height: 54.3906px;" colspan="2" width="91">
<p><strong>&nbsp;3</strong></p>
</td>
</tr>
<tr style="height: 76.7812px;">
<td style="width: 37.246%; height: 76.7812px;" colspan="4" width="218">
<p>&nbsp;</p>
</td>
<td style="width: 15.3211%; height: 76.7812px;" colspan="2" width="172">
<p><strong>No sounds </strong></p>
</td>
<td style="width: 10.3368%; height: 76.7812px;" width="78">
<p><strong>&nbsp;1</strong></p>
</td>
<td style="width: 27.5647%; height: 76.7812px;" colspan="2" width="191">
<p><strong>&nbsp;Extension </strong></p>
</td>
<td style="width: 9.47536%; height: 76.7812px;" width="91">
<p><strong>&nbsp;2</strong></p>
</td>
</tr>
<tr style="height: 54.3906px;">
<td style="width: 62.9038%; height: 54.3906px;" colspan="7" width="468">
<p>&nbsp;</p>
</td>
<td style="width: 27.5647%; height: 54.3906px;" colspan="2" width="191">
<p><strong>No motor response </strong></p>
</td>
<td style="width: 9.47536%; height: 54.3906px;" width="91">
<p><strong>&nbsp;1</strong></p>
</td>
</tr>
</tbody>
</table>
<p><strong>Table 2: Classification of head injury based on GCS</strong></p>
<table style="border-collapse: collapse; width: 83.3034%; height: 244px;" border="1">
<tbody>
<tr>
<td style="width: 27.518%;" width="108">
<p><strong>Minor</strong></p>
</td>
<td style="width: 72.482%;" width="306">
<p>GCS 15 with no LOC</p>
</td>
</tr>
<tr>
<td style="width: 27.518%;" width="108">
<p><strong>Mild</strong></p>
</td>
<td style="width: 72.482%;" width="306">
<p>GCS 14 or 15 with LOC</p>
</td>
</tr>
<tr>
<td style="width: 27.518%;" width="108">
<p><strong>Moderate</strong></p>
</td>
<td style="width: 72.482%;" width="306">
<p>GCS 9 &ndash; 13</p>
</td>
</tr>
<tr>
<td style="width: 27.518%;" width="108">
<p><strong>Severe</strong></p>
</td>
<td style="width: 72.482%;" width="306">
<p>GCS 3 &ndash; 8</p>
</td>
</tr>
</tbody>
</table>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 51</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Partial obstruction of trachea by epiglottis results in: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Snoring</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Stridor</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Rhonchi</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Wheezing</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li><strong>Stridor</strong> is a high-pitched, wheezing sound caused by an obstruction or narrowing in the upper airways, such as the trachea or larynx. If the <strong>epiglottis</strong> partially obstructs the trachea, it can block airflow and lead to this characteristic sound during breathing. Stridor is often more pronounced during inhalation.</li>
<li><strong>Snoring:</strong> Snoring is typically caused by vibration of tissues in the throat due to partial airway obstruction, but it is not the same as stridor. Snoring usually occurs during sleep and is a lower-pitched sound compared to stridor.</li>
<li><strong>Rhonchi:</strong> Rhonchi are low-pitched, rattling sounds often associated with the lower airways (bronchi) due to secretions or mucus, usually heard in conditions like bronchitis, rather than in cases of tracheal obstruction.</li>
<li><strong>Wheezing:</strong> Wheezing is a high-pitched sound usually caused by narrowing of the smaller airways (bronchioles) in conditions like asthma or COPD. It occurs primarily during exhalation, not as a result of epiglottic obstruction of the trachea.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 52</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is involved with the incorrect use of spacer in MDI?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Require more coordination to inhale drug</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Reduces deposition of drug in mouth</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Increase drug in lungs</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Less chances of mouth infection</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Spacer is a device that connects to the MDI and patient inhales drug from the spacer.</li>
<li>This causes lesser deposition of steroid in oropharyngeal cavity and hence lesser oropharyngeal candidiasis and systemic side-effects are seen.</li>
<li>This device makes it easier to use MDI in children.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 53</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Exclusive breastfeeding should be continued up to which age? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>4 months</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>6 months</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>8 months</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>12 months</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>WHO also recommends exclusive breastfeeding up to 6 months of age with continued breastfeeding along with appropriate complementary foods up to 2 years of age or longer.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 54</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following is not included in active management of the 3rd stage of labor? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Uterine massage</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>CCT</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Oxytocin injection</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Early cord clamping</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Active management of the third stage of labor involves giving a prophylactic uterotonic, early cord clamping and controlled cord traction (CCT) to deliver the placenta.</li>
</ul>
<p><strong>Third stage of labor: </strong></p>
<ul>
<li>Third stage of labor extends from the birth of child to complete expulsion of placenta and membrane.</li>
<li>Normal duration of third stage in passive management of third stage of labor- 15 - 20 min.</li>
<li>In active management 5 - 10 minutes.</li>
<li>Third stage is said to prolonged if it is &gt; 30 minutes.</li>
<li>In the absence of excessive bleeding, up to 30 min may be allowed before intervention.</li>
</ul>
<p><strong>Table 1: Stages of Labor</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 34.8921%;" colspan="3" width="271">
<p>&nbsp;</p>
</td>
<td style="width: 40.1079%;" colspan="2" width="264">
<p><strong>&nbsp;Duration</strong></p>
</td>
<td style="width: 25%;" width="228">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td style="width: 17.446%;" colspan="2" width="105">
<p><strong>Stage</strong></p>
</td>
<td style="width: 17.446%;" width="166">
<p><strong>Starts/ Ends</strong></p>
</td>
<td style="width: 19.7842%;" width="126">
<p><strong>Primiparous</strong></p>
</td>
<td style="width: 20.3237%;" width="138">
<p><strong>Multiparous</strong></p>
</td>
<td style="width: 25%;" width="228">
<p><strong>Abnormalities</strong></p>
</td>
</tr>
<tr>
<td style="width: 6.29496%;" rowspan="2" width="36">
<p>1<sup>st</sup></p>
</td>
<td style="width: 11.1511%;" width="70">
<p>Latent</p>
</td>
<td style="width: 17.446%;" width="166">
<p>Onset of labor to 3 &ndash; 4 cm dilation.</p>
</td>
<td style="width: 19.7842%;" width="126">
<p>6 &ndash; 11 hours</p>
</td>
<td style="width: 20.3237%;" width="138">
<p>4 &ndash; 8 hours</p>
</td>
<td style="width: 25%;" width="228">
<p>Prolongation seen with excessive sedation/ hypotonic uterine contractions.</p>
<p><strong>Management:</strong> Rest and sedation</p>
</td>
</tr>
<tr>
<td style="width: 11.1511%;" width="70">
<p>Active</p>
</td>
<td style="width: 17.446%;" width="166">
<p>4 cm to complete cervical dilation (10 cm).</p>
</td>
<td style="width: 19.7842%;" width="126">
<p>4 &ndash; 6 hours (1.2 cm/hour)</p>
</td>
<td style="width: 20.3237%;" width="138">
<p>2 &ndash; 3 hours (1.5 cm/hour)</p>
</td>
<td style="width: 25%;" width="228">
<p><strong>Prolongation:</strong> Cervical dilation of &lt; 1.2 cm/h</p>
<p>(primipara) / &lt; 1.5 cm/h (multipara)</p>
<p><strong>Arrest:</strong> No cervical change in &ge; 2 h</p>
<p><strong>Cause:</strong> These abnormalities are seen in passenger (fetal size or abnormal presentation), pelvis, or power (dysfunctional contractions).</p>
<p><strong>Management:</strong></p>
<p>IV oxytocin &rarr; Hypotonic contractions</p>
<p>Emergency cesarean</p>
<p>section &rarr; Adequate contractions</p>
</td>
</tr>
<tr>
<td style="width: 17.446%;" colspan="2" width="105">
<p>2<sup>nd</sup></p>
</td>
<td style="width: 17.446%;" width="166">
<p>Complete cervical dilation to delivery of infant.</p>
</td>
<td style="width: 19.7842%;" width="126">
<p>0.5 &ndash; 3.0 hours</p>
</td>
<td style="width: 20.3237%;" width="138">
<p>5 &ndash; 30 minutes</p>
</td>
<td style="width: 25%;" width="228">
<p><strong>Second-stage arrest:</strong></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Failure to deliver within 1 hour (multipara) or 2 hours (Nullipara)</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Add additional 1 hour if epidural</p>
<p><strong>Cause:</strong> This abnormality is seen in passenger, pelvis, or power.</p>
<p><strong>Management:</strong></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Cesarean &rarr; Fetal head is not engaged</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Trial of obstetric forceps or vacuum extraction &rarr; Fetal head is engaged</p>
</td>
</tr>
<tr>
<td style="width: 17.446%;" colspan="2" width="105">
<p>3<sup>rd</sup></p>
</td>
<td style="width: 17.446%;" width="166">
<p>Delivery of infant to delivery of placenta.</p>
</td>
<td style="width: 19.7842%;" width="126">
<p>0 &ndash; 0.5 hour</p>
</td>
<td style="width: 20.3237%;" width="138">
<p>0 &ndash; 0.5 hour</p>
</td>
<td style="width: 25%;" width="228">
<p><strong>Prolonged third stage:</strong></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Failure to deliver placenta within 30 minutes</p>
<p><strong>Cause:</strong> Consider placenta percreta/ accreta/increta</p>
<p><strong>Management:</strong></p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; IV oxytocin</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; If oxytocin fails, attempt manual removal</p>
<p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Hysterectomy may be needed</p>
</td>
</tr>
</tbody>
</table>
<p><strong>Table 2: Failure to Progress &nbsp;</strong></p>
<table style="border-collapse: collapse; width: 100%;" border="1">
<tbody>
<tr>
<td style="width: 16.9065%;" width="101">
<p><strong>&nbsp;Stage</strong></p>
</td>
<td style="width: 32.1942%;" width="221">
<p><strong>&nbsp;Definition</strong></p>
</td>
<td style="width: 50.8993%;" width="385">
<p><strong>&nbsp;Treatment</strong></p>
</td>
</tr>
<tr>
<td style="width: 100%;" colspan="3" width="707">
<p><strong>&nbsp;&nbsp;First Stage: Failure to have progressive cervical change</strong></p>
</td>
</tr>
<tr>
<td style="width: 16.9065%;" width="101">
<p><strong>Latent</strong></p>
</td>
<td style="width: 32.1942%;" width="221">
<p>&bull; <strong>Prima:</strong> &gt; 20 hours</p>
<p>&bull; &nbsp;<strong>Multi:</strong> &gt; 14 hours</p>
</td>
<td style="width: 50.8993%;" width="385">
<p>Therapeutic rest via parenteral analgesia; oxytocin; amniotomy; cervical ripening.</p>
</td>
</tr>
<tr>
<td style="width: 16.9065%;" width="101">
<p><strong>Active</strong></p>
</td>
<td style="width: 32.1942%;" width="221">
<p>&bull; &nbsp;<strong>Prima:</strong> &gt; 2 hours</p>
<p>&bull; &nbsp;<strong>Multi:</strong> &gt; 2 hours after reaching 3 &ndash; 4 cm</p>
</td>
<td style="width: 50.8993%;" width="385">
<p>Amniotomy; oxytocin; C-section if the previous interventions are ineffective.</p>
</td>
</tr>
<tr>
<td style="width: 100%;" colspan="3" width="707">
<p><strong>&nbsp;&nbsp;Second Stage: Arrest of fetal descent</strong></p>
</td>
</tr>
<tr>
<td style="width: 16.9065%;" rowspan="2" width="101">
<p>&nbsp;</p>
</td>
<td style="width: 32.1942%;" width="221">
<p><strong>Prima:</strong> &gt; 2 hours; &gt; 3 hours with epidural</p>
</td>
<td style="width: 50.8993%;" width="385">
<p>Close observation with a &darr; in epidural rate and continued oxytocin.</p>
</td>
</tr>
<tr>
<td style="width: 32.1942%;" width="221">
<p><strong>Multi:</strong> &gt; 1 hour; &gt; 2 hours with epidural</p>
</td>
<td style="width: 50.8993%;" width="385">
<p>&bull; &nbsp;Assisted vaginal delivery (forceps or vacuum).</p>
<p>&bull; &nbsp;C-section</p>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 55</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Which of the following gas is used to create pneumoperitoneum during surgery? </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Oxygen</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Carbon dioxide</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nitrogen</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Nitrous oxide</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Carbon dioxide is the most frequently used gas for insufflation of the abdominal cavity (pneumoperitoneum).</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 56</h3>
                <p><b>During the surgery of breast cancer, the breast surgeon needs to take a sentinel lymph node biopsy. Which of the given below procedures will be used by the surgeon to take a biopsy? </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Gamma probe</li><li>2. Laparoscope</li><li>3. Endoscope</li><li>4. Colposcope</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Sentinel node is the first node involved from a tumor. Sentinel node biopsy is commonly used for cancers of breast, malignant melanoma and cancer penis.</li><li><b>How to do SNB:</b> Day before surgery/or on the same day of surgery inject Technetium 99m sulfur colloid in the breast parenchyma or around the tumor, this activity can be measured <b>using gamma probe during surgery</b>. The node with high activity is sentinel node. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 57</h3>
                <p><b>Choice of fluid in children with moderate dehydration is: </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. D 5%</li><li>2. D 10%</li><li>3. Normal saline</li><li>4. NS 5%</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The simplest approach is to replace dehydration losses with 0.9% saline. This ensures that the administered fluid remains in the extracellular (intravascular) compartment, where it will do the most good to support blood pressure and peripheral perfusion.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 58</h3>
                <p><b>Which among the following causes the occurrence of symptoms of bipolar disorder? (MHN)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Physical activity</li><li>2. Return on previous performance level of work</li><li>3. Reduced sleep</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Return on previous performance level of work may cause the occurrence of symptoms of bipolar disorder as goal attainment and other positive events can also produce mood episodes, chiefly mania or hypomania.</li><li>Physical activity helps to reduce the provoking factors related to the bipolar disorder.</li><li>Reduced sleep is a manifestation of bipolar disorder, not a direct risk factor.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 59</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>PDSA stands for:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Plan, do, study, act</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Plan, define, simplify, act</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Plan, define, simplify, assume</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Perform, due, simplify, act</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>PDSA stands for Plan, do, study, act. The PDSA model is used to bring change or improve a process through a problem-solving approach.</li>
</ul>
<p><img title="image033.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/59c313f8-8456-4d6d-99fe-2f619c947ee7.png" alt="" width="210" height="134" /></p>
<p><strong>Figure: PDSA</strong></p>
<ul>
<li><strong>Stage 1: Plan</strong>
<ul>
<li>In stage 1, a team is recruited that defines an &ldquo;aim statement&rdquo; for the expected outcome. Following this, they describe the current context and processes. Once it is done, the &ldquo;problem is described&rdquo; and its causes and alternatives are identified.</li>
</ul>
</li>
<li><strong>Stage 2: Do</strong>
<ul>
<li>In this stage, the plan made in previous stage is implemented.</li>
</ul>
</li>
<li><strong>Stage 3: Study</strong>
<ul>
<li>In this stage, various tools like a &lsquo;Pareto chart, control chart, or run chart&rsquo; are used to assess the extent of improvement.</li>
</ul>
</li>
<li><strong>Stage 4: Act</strong>
<ul>
<li>Based on the data collected in the previous stage, the team reflects on the plan and the outcome. If an improvement is noticed, it is standardized and used on regular basis but if no improvement is recorded, a new approach is adopted and they restart the entire cycle from stage 1.</li>
</ul>
</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 60</h3>
                <p><b>What is the typical urine output of a healthy adult?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 100 mL</li><li>2. 500 mL</li><li>3. 1500 mL</li><li>4. 2500 mL</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The normal range (healthy individuals) for 24-hour urine volume is about 800 - 2000 mL per day when the intake of fluid normally is about 2 liters every day. In the above options, 1500 mL lies within this range, hence it is the correct answer.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 61</h3>
                <p><b>A fluid that causes shifting of fluid from cells to blood:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Hypertonic</li><li>2. Hypotonic</li><li>3. Isotonic</li><li>4. Isotope</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>A fluid that causes shifting of fluid from cells to blood is known as the hypertonic solution as the hypertonic solution has higher concentration of solute and lower concentration of solvent than the blood plasma, therefore, it pulls fluid from the cells into the blood as the solvent moves along a gradient from higher to lower concentration.</li><li>Hypotonic solutions have less concentration of solutes and more concentration of solvent, hence the fluid (solvent) moves into the cells.</li><li>In isotonic solution, there is no fluid shift as both the concentration of cell and blood plasma are equal.</li><li>Isotope is a distractor.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 62</h3>
                <p><b>Premature babies have more chances of hypothermia because of all of the following, EXCEPT: (PEDIA)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Cold environment</li><li>2. Less developed epidermis</li><li>3. Less brown fat</li><li>4. Small body surface area in comparison of weight</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Premature babies have more chances of hypothermia because of all of the above, EXCEPT that premature babies have small body surface area in comparison of weight. Usually, the premature babies develop hypothermia due to the large body surface area in relation to weight that results in more heat loss from the body leading to hypothermia.</li><li>Other options are incorrect as they are the causes of hypothermia in a premature.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 63</h3>
                <p><b>Which of the following is NOT included in Mission Indradhanush? (CHN)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Measles</li><li>2. DPT</li><li>3. PCV</li><li>4. Hepatitis B</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><p>The Mission Indradhanush program provides vaccination against eight life-threatening diseases and these are:</p><ul><li>Diphtheria, whooping cough, tetanus (DPT)</li><li>Hemophilus influenzae type B (Hib) causing pneumonia and meningitis,</li><li>Polio</li><li>Tuberculosis</li><li>Measles</li><li>Hepatitis B</li></ul><p>Therefore, the only vaccine which is not a part of this program is PCV.</p><p>&nbsp;</p></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 64</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>How often is the MSE conducted ? (MHN)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>24 hours</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>6 hours</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2 weeks</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 month</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>For an admitted patient with acute disease, MSE is advised to be conducted in every shift, so 6 hours is the correct answer. For others, the gap between 2 MSE should be of about 3 months.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 65</h3>
                <p><b>Which type of bandage is used for the ankle joint? (FON)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Spiral</li><li>2. Reverse spiral</li><li>3. Figure of 8</li><li>4. Circular</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Type of bandage is used for the ankle joint is Figure of 8. In this type of bandage, that turns by crossing each other like the figure eight. Such type of dressing is used to retain dressings, to exert pressure for joints, to fix splints for the foot or hand, for the great toe and for sprains or hemorrhage. This is considered best for the joints as it ensures proper coverage of the area.</li><li>Spiral bandage provides support to damaged muscle tissues specially of limbs.</li><li>Reverse spiral bandage is preferred for bandaging the limbs as it follows the contours of the limbs to apply the required pressure.</li><li>Circular bandaging is used to hold dressings on body parts such as arms, legs, chest or abdomen.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 66</h3>
                <p><b>What a nurse will not do while administering KCl? (FON)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Mix in the NS saline and slow infusion</li><li>2. Give some fruits juice</li><li>3. Monitoring of intake and output</li><li>4. Administer the KCl bolus</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The nurse must not administer the KCl bolus because if it is injected too rapidly or in too high a dose, it may cause cardiac arrest within minutes.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 67</h3>
                <p><b>India crossed 100 crore vaccination on:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 19th October, 2021</li><li>2. 20th October, 2021</li><li>3. 21st October, 2021</li><li>4. 22nd October, 2021</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>India crossed 100 crore vaccination on 21st October, 2021.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 68</h3>
                <p><b>Cannula used for blood transfusion is: </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 18G</li><li>2. 21G</li><li>3. 22G</li><li>4. 23G</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Cannula used for blood transfusion is 18G. This size of cannula is preferred as it prevents damage to the red blood cells and provide an adequate rate of flow.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 69</h3>
                <p><b>Length of child doubles by: (PEDIA)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 2 years</li><li>2. 3 years</li><li>3. 4 years</li><li>4. 5 years</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Length of child doubles by 4 years and it triples at 12 years.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 70</h3>
                <p><b>According to Govt. of India, the emergency contraceptive is: (OBG)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Levonorgestrel 1.5 mcg</li><li>2. Levonorgestrel 1.5 mg</li><li>3. Levonorgestrel 150 mg</li><li>4. Progestogen-only pill (POPs)</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>Under the National Reproductive and Child Health Programme, the Drug Controller of India has only approved Levonorgestrel (LNG) 0.75mg tablets for use as ECP. LNG is the dedicated product&rsquo; for emergency contraception and is specially packaged at the correct dosage for use as ECP. H</li><li>The emergency contraceptive pills must be preferably taken within 72 hours of an unprotected act of intercourse, the earlier the better. Best if taken as soon as possible after the unprotected act and as a single dose of 1 tablet of 1.5mg or 2 tablets of 0.75mg each. There is an option of taking 2 doses of 1 tablet 0.75mg each, 12 hours apart too.</li></ul></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 71</h3>
                <p><b>Which of the following is not given to lactating mothers? (OBG)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. DMPA</li><li>2. POP</li><li>3. Mini pills</li><li>4. Combined OCPs</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Combined OCPs are not given to lactating mothers as it contains estrogen and estrogen usually effects locally along with progesterone to prevent the secretion of milk from the breasts during pregnancy. As soon as birth of the baby occur, the levels of estrogen falls which leads to secretion of milk from the breasts.</li><li>Other methods of contraception do not interfere with breastfeeding.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 72</h3>
                <p><b>Cu-T is not inserted in: (OBG)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Unexplained vaginal bleeding</li><li>2. Multiparous female</li><li>3. After delivery</li><li>4. Anemia</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Cu-T is not inserted in unexplained vaginal bleeding as Cu-T itself causes vaginal bleeding as a side-effect which is not pathologically significant but if already a woman has unexplained vaginal bleeding, there could be a serious pathology behind it which is overlooked because of Cu-T insertion.</li><li>In all other conditions, Cu-T can be inserted.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 73</h3>
                <p><b>Which muscle has no role in episiotomy? (OBG)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Ischiocavernosus</li><li>2. Superior Transverse perineal muscles</li><li>3. Deep transverse perineal muscles</li><li>4. Bulbospongiosus</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>Episiotomy involves cutting of:<ul style="list-style-type: circle;"><li>Posterior vaginal wall</li><li>Superior and deep transverse perineal muscles</li><li>Bulbospongiosus</li><li>Part of levator ani</li><li>Fascia covering those muscles</li><li>Transverse perineal branches of pudendal vessels and nerves</li></ul></li><li>Therefore, the correct answer is &ldquo;Ischiocavernosus&rdquo; as it is not involved in episiotomy.</li></ul></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 74</h3>
                <p><b>Which of the following is not a symptom of acute renal failure?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Hyponatremia</li><li>2. Hypokalemia</li><li>3. Metabolic alkalosis</li><li>4. Metabolic acidosis</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Metabolic alkalosis is not a symptom of acute renal failure as Acute renal failure is associated with electrolyte and acid-base disturbances such as hyperkalemia, metabolic acidosis, hypocalcemia and hyperphosphatemia. In this condition, the kidney is unable to remove the unnecessary acids from the body, which causes metabolic acidosis.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 75</h3>
                <p><b>If a nurse is using 4 size of ET tube, which size of suction catheter will be used by her?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 6 fr</li><li>2. 8 fr</li><li>3. 10 fr</li><li>4. 12 fr</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><p>If a nurse is using 4 size of ET tube, the size of suction catheter will be used 8 Fr as:</p><table style="border-collapse: collapse; width: 100%;" border="1"><tbody><tr><td style="width: 41.2195%;"><p><strong>ETT Size (mm)</strong></p></td><td style="width: 58.6992%;"><p><strong>Suction Catheter Size</strong></p></td></tr><tr><td style="width: 41.2195%;"><p><strong>2.5</strong></p></td><td style="width: 58.6992%;"><p><strong>5 Fr</strong></p></td></tr><tr><td style="width: 41.2195%;"><p><strong>3.0 - 3.5</strong></p></td><td style="width: 58.6992%;"><p><strong>6 - 7 Fr</strong></p></td></tr><tr><td style="width: 41.2195%;"><p><strong>4.0 - 4.5</strong></p></td><td style="width: 58.6992%;"><p><strong>8 Fr</strong></p></td></tr></tbody></table><ul><li>Other options are distractors.</li></ul></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 76</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A nurse measures the temperature of the child as 38.2&deg;C. What will be his temperature in Fahrenheit?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>101.4&deg;F</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>102.6&deg;F</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>100.7&deg;F</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>99.8&deg;F</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p>To convert the temperature in Celsius to Fahrenheit, use the formula:</p>
<p>&deg;F = &deg;C &times; (9/5) + 32</p>
<p>Where,</p>
<ul>
<li>C = Measure of temperature in degree Celsius (&deg;C).</li>
<li>F = Measure of temperature in degree Fahrenheit (&deg;F).</li>
</ul>
<p>To convert Celsius to Fahrenheit, we can follow the steps given below:</p>
<ul>
<li><strong>Step 1:</strong>&nbsp;Identify the temperature value in Celsius.</li>
<li><strong>Step 2:</strong>&nbsp;Multiply the given temperature by 9.</li>
<li><strong>Step 3:</strong>&nbsp;Divide the product by 5.</li>
<li><strong>Step 4:</strong>&nbsp;Add 32 to that number. That will be the required value in degree Fahrenheit (&deg;F).</li>
</ul>
<p>In this case,</p>
<p>&deg;F = 38.2 &times; 9/5+32</p>
<p>= 100.76 &deg;F</p>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 77</h3>
                <p><b>What does fr indicate in 20 fr of urinary catheter?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Inner circumference of catheter</li><li>2. Outer circumference of catheter</li><li>3. Radius of catheter</li><li>4. Length of catheter</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The French size is a measure of the outer diameter/circumference of a catheter (not internal drainage channel, or inner diameter). The French gauge was devised by Joseph-FrÃ©dÃ©ric-BenoÃ®t CharriÃ¨re. </li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 78</h3>
                <p><b>Bandlâ€™s ring is known as a pathological ring, if there is:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Precipitated labor</li><li>2. Obstructed labor</li><li>3. Deep transverse arrest</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Bandlâ€™s ring is known as a pathological ring, if there is obstructed labor. Bandlâ€™s ring is the abnormal junction between the two segments of the human uterus, which is a late sign associated with obstructed labor. Before the onset of labor, the junction between the lower and upper uterine segments is a slightly thickened ring.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 79</h3>
                <p><b>What is correct about the use of AED?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Used for cardiac arrest patient by medical professionals</li><li>2. Used for elderly patients in cardiac arrest by a person with medical training</li><li>3. Not used for child below 8 years age and by a medical personnel</li><li>4. It can be used for any age group by any person</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Correct about the use of AED is that it can be used for any age group by any person. AEDs (Automated external defibrillators) are used to give the public easy access to defibrillators and it can be used on a victim of any age by people with no medical training. It is advisable to use pediatric pads if AED is used for a child below the age of 8 years.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 80</h3>
                <p><b>In an emergency, patient is admitted with cardiac arrest. Which pulse is used to assess PR in the patient?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Carotid</li><li>2. Brachial</li><li>3. Apical</li><li>4. Femoral</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>In an emergency, for an adult patient with cardiac arrest, carotid pulse is used to assess the pulse rate. The carotid pulse is checked for a minimum of 5 secondsâ€”but no more than 10 secondsâ€”to determine if there is a pulse present.</li><li>Brachial pulse is preferred in infants.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 81</h3>
                <p><b>Which of the following site is not used in emergency for infusion?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Medial end of clavicle</li><li>2. Distal end of tibia</li><li>3. Distal end of femur</li><li>4. Proximal end of tibia</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Medial end of clavicle is not used in emergency for infusion. The proximal tibia, humeral head and sternum are the preferred sites in adults. The distal femur, proximal tibia and distal tibia are preferred sites for infants and neonates. </li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 82</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>WHO, recommended time for hand washing by hand rub is: (FON)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>20 to 30 sec</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>40 to 60 sec</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 to 3 min</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3 to 5 min</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>By WHO, recommended time for hand washing by hand rub is 20 to 30 sec. The hand rub has to be applied on one palm first and then it is rubbed between the hands and all the surfaces of hands are rubbed until dry.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 83</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Disinfection of elastic endoscope is done by using: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ethylene oxide</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Glutaraldehyde</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Formaldehyde</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hydrogen peroxide</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<p>An elastic endoscope is usually disinfected with glutaraldehyde, as it is the most widely used chemical for high-level disinfection of heat-sensitive medical devices, such as endoscopes, including their elastic versions. In contrast to ethylene oxide, glutaraldehyde can be employed in a cold sterilization process, which is essential for preserving delicate instruments like endoscopes.</p>
<p>Other options are distractors.</p>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 84</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Transmission based precautions are:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Airborne, contact and universal precautions</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Airborne, droplets and contact precautions</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Universal precaution, vaccination, prevention of needlestick injury</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>PPE, airborne and contact precautions</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Transmission based precautions are airborne, droplets and contact precautions. It is the second tier of basic infection control and is used besides Standard precautions.</li>
</ul>
<p><img title="image035.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/90a833e7-a8d7-443f-90fb-81314d679dda.jpg" alt="" width="485" height="273" /></p>
<p><strong>Figure: Infectious Disease Precautions </strong></p>
<ul>
<li>Other options are distractors.</li>
</ul>
<p>&nbsp;</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 85</h3>
                <p><b>During doffing, PPE is removed in which order? (FON)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Goggles, mask, gloves, gown</li><li>2. Gown, mask, goggles, gloves</li><li>3. Mask, goggles, gloves, gown</li><li>4. Gloves, gown goggles, mask</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>Doffing method that CDC recommends on its website are:<ol><li>Remove <strong>gloves</strong></li><li>Remove <strong>gown</strong></li><li>Healthcare personnel may now exit patient room.</li><li>Perform hand hygiene.</li><li>Remove face shield or <strong>goggles</strong></li><li>Remove and discard respirator (or <strong>facemask</strong> if used instead of respirator).</li></ol></li><li>Other options are distractors</li></ul></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 86</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>During delivery, there is a laceration in vaginal mucosa involving some perineal muscles, but not involving the anal sphincter. Identify the degree of tear: (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>First</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Second</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Third</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Fourth</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The degree of tear here will be second degree as:</li>
</ul>
<p><img title="image037.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f9707065-08d0-4dcb-a086-4b9142ab2b20.jpg" alt="" width="554" height="253" /></p>
<p><strong>Figure: Degree of Vaginal Tear</strong></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 87</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A placenta that is partially or completely attached to myometrium without disbursing the decidua is called: (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Placenta accreta</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Increta</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Percreta</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Placenta succunturiata</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>A placenta that is partially or completely attached to myometrium without disbursing the decidua is called Placenta accrete.</li>
<li>Other options are incorrect as:</li>
</ul>
<p><img title="image039.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/01e0e7e4-45a1-44d5-83a8-47aef44fdcf8.jpg" alt="" width="486" height="270" /></p>
<p><strong>Figure: Normal Placenta Vs Placenta Accreta Spectrum</strong></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 88</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The life expectancy of patients with schizophrenia is reduced by:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10 to 20 year of age</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>20 t0 30 years of age</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>30 to 40 years of age</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>15 - 25 years of age</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The life expectancy of patients with schizophrenia is reduced by between 15 to 25 years.</li>
<li>Other options are distractors.</li>
</ul>
</body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 89</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Complete bowel obstruction results in all, except: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bilious vomiting</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Infection</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Diarrhea</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Abdominal pain</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Complete bowel obstruction results in all, except diarrhea as it is seen in partial bowel obstruction while constipation is evident in complete bowel obstruction. All others are signs of complete bowel obstruction.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 90</h3>
                <p><b>Which antiepileptic is given by intranasal route in an emergency?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Valproate</li><li>2. Midazolam</li><li>3. Phenytoin</li><li>4. Gabapentin</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Midazolam antiepileptic is given by intranasal route in an emergency, especially for treating cluster and prolonged seizures. The drug gets quickly absorbed in the nasal mucosa and can effectively control seizures within first 10 minutes.</li><li>Other options are incorrect as none of them can be given through intranasal route.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 91</h3>
                <p><b>A lactating mother is suffering from mastitis and she went to the clinic for the check-up. After the assessment, breast abscess is diagnosed in one of the breast. Identify the measure taken by the mother: (OBG)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. No breastfeeding by both breasts</li><li>2. Continue breastfeeding by opposite breast</li><li>3. Give formula food</li><li>4. Give cow milk</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Continue breastfeeding by opposite breast is the measure to be taken to allow the affected breast to heal properly. This will also prevent the baby to develop malnutrition or any risk of infection or digestive problems related to formula food or cowâ€™s milk.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 92</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>How a nurse will administer an injection of dextran iron to a patient?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>At the angle of 45&deg; intramuscularly</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pull the skin lateral towards site of injection</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Use Z track technique</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Remove the needle at 45&deg;</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Injection of dextran iron has to be given through Z track method as in this method the drug is inserted deep intramuscularly in a zig-zag manner that helps in preventing the leakage of the drug into the subcutaneous tissue, locks the drug, prevents discoloration due to drug and it also decreases skin irritation.</li>
</ul>
<p><img title="image041.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/8b2cece3-910d-4d69-97db-99552e81e03f.jpg" alt="" width="496" height="300" /></p>
<p><strong>Figure: Intramuscular Injections</strong></p>
<ul>
<li>Other options are distractors.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 93</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A patient complains of pain, HR 76 beats/ min, RR 24/min, BP 90 mmHg, temp. 37.6 degree. What will be the 5th vital sign?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>RR</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>HR</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>BP</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Pain</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Pain is the fifth vital sign as it was usually ignored by the health professionals because it is the right of the patient to be free of pain if pain is easily characterized or located.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 94</h3>
                <p><b>Which congenital heart disease is associated with minimum chances of heart failure?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Transposition of great arteries</li><li>2. ASD</li><li>3. VSD</li><li>4. Patent ductus arteriosus</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Transposition of great arteries is a congenital heart disease associated with minimum chances of heart failure as it is a cyanotic congenital heart defect while all others are acyanotic congenital heart defects. As per the studies, congestive heart failure is more commonly seen in acyanotic heart defects as these defects tend to send more blood to lungs which built an extra pressure there, eventually causing the heart muscles to weaken and heart is unable to pump the blood properly (heart failure).</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 95</h3>
                <p><b>Hormone responsible for lactation:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Prolactin</li><li>2. GH</li><li>3. FSH</li><li>4. HCG</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Prolactin is the hormone responsible for lactation. Prolactin (PRL) is released from lactotrophs of the anterior pituitary gland when the baby sucks the nipple. It is the major hormonal signal responsible for stimulation of milk synthesis in the mammary glands.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 96</h3>
                <p><b>Difference between systolic and diastolic blood pressure is called:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Pulse pressure</li><li>2. Pulse deficit</li><li>3. Auscultatory gap</li><li>4. Korotkoff sounds</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Difference between systolic and diastolic blood pressure is called pulse pressure. It is measured in millimeters of mercury (mmHg). It signifies the force that the heart generates every time it contracts. A normal resting blood pressure is approximately 120/80 mmHg, which produces a pulse pressure of approximately 40 mmHg.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 97</h3>
                <p><b>Which bone is called the Breast Bone?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Sternum</li><li>2. Clavicle</li><li>3. Forearm</li><li>4. Radius</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Sternum is the called the breast bone. It is made up of tetrapods (four-limbed vertebrates), elongated bone in the center of the chest that articulates with and provides support for the clavicles (collarbones) of the shoulder girdle and for the ribs.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 98</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is the daily additional calories required for pregnant women? (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>300 calories</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>500 calories</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>100 calories</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>800 calories</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Daily additional calories required for pregnant women is 300 calories in second and third trimesters.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 99</h3>
                <p><b>Iron and folic acid dose in pregnant woman is: (OBG)</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 60 mg iron, 0.4 mg folic acid</li><li>2. 30 mg iron, 0.4 mg folic acid</li><li>3. 100 mg iron, 0.3 mg folic acid</li><li>4. 60 mg iron, 0.2 mg folic acid</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Iron and folic acid dose in pregnant woman is 60 mg iron, 0.4 mg folic acid. As per the WHO recommendations, daily oral iron and folic acid supplementation with 30 mg to 60 mg of elemental iron and 400 Âµg (0.4 mg) or 0.4mg folic acid is recommended for pregnant women to prevent maternal anemia, puerperal sepsis, low birth weight and preterm birth.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 100</h3>
                <p><b>Which is a high pitched lung sound?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Wheezes</li><li>2. Rhonchi</li><li>3. Rales</li><li>4. Course crackles</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Wheezes are the high pitched whistling sounds those are usually generated due to narrowed airways. These sounds sometimes can even be heard without a stethoscope. Wheezes can be heard both during inhalation and exhalation but they are louder during exhalation and indicates milder obstruction while when they are heard during inspiration as well as expiration, the cause is more serious.</li><li><b>Rhonchi</b> is snoring like sound and are heard due to blockage of air flow through the large airways. These are low-pitched wheezes or coarse crackles, those are nonrepetitive, nonmusical sounds heard during both inhalation and exhalation.</li><li><b>Rales</b> are small clicking, bubbling, or rattling sounds in the lungs usually heard during inhalation and are caused when the air opens the closed air spaces. Rales can be moist, dry, fine, or coarse in nature.</li><li><b>Course crackles</b> are low-pitched bubbling or gurgling sound that is not cleared by coughing.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 101</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>In typhoid what type of fever is common?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Step ladder fever</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Intermittent fever</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Continuous fever</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Relapsing fever</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Step ladder fever is common in typhoid which is characterized by rising temperature throughout the day that drops by subsequent morning giving a step ladder appearance when plotted on a graph like:</li>
</ul>
<p><img title="image043.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/34d79293-1cbd-4171-ab2e-473b558d8303.jpg" alt="" width="288" height="172" /></p>
<p><strong>Figure: </strong>Step Ladder Fever</p>
<ul>
<li>The peaks and troughs rise progressively with time.</li>
<li>Other options are distractors.</li>
<li><strong>Intermittent fever</strong> is mostly seen in patients with focal bacterial infections.</li>
<li><strong>Continuous fever</strong> are characteristics of lobar and gram-negative pneumonia, typhoid, acute bacterial meningitis, urinary tract infection, among others.</li>
<li><strong>Relapsing fever</strong> is seen in patients who are infected with <strong>several species of the Spirochete Borrelia</strong>and transmitted by lice or ticks.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 102</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Most common cause of PPH: (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Placental Abruptio</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Placenta previa</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Uterine atony</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Anemia</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Uterine atony is the most common cause of PPH because uterine atony means that the uterus has lost its tone which means the uterine muscles fails to contract. Normally, the contraction of uterus stops bleeding from the site from where the placenta got separated. But, when there is uterine atony the bleeding does not stop and leads to postpartum hemorrhage.</li>
<li>Placenta abruptio and Placenta previa are cause of APH.</li>
<li>Anemia is a clinical manifestation of PPH.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 103</h3>
                <p><b>HPV vaccine is used to prevent which among the following cancer?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Cervical cancer</li><li>2. Breast cancer</li><li>3. Stomach cancer</li><li>4. Lung cancer</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>HPV or Human Papillomavirus (HPV) vaccine is used to prevent cervical cancer, vaginal cancer, vulvar cancer and genital warts. This has been approved by the U.S. Food and Drug Administration and can be used for both girls and boys.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 104</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Postpartum care for abscess and lump in right breast and fever: (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Continue Breastfeeding from both breasts</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Left Breast Feeding</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Vitamin B6</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Give Bromocriptine</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Left breastfeeding will be the correct answer as the infection is in the right breast and as that infection can be transferred from mother to the baby and will also worsen the condition of the mother, the baby is fed from the left breast to meet his nutritional requirements.</li>
<li>Vitamin B<sub>6</sub> and Bromocriptine are not the care of choice as they are given to decrease the milk production in breast which is not required in this case.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 105</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>All are the methods used for the removal of placenta, except: (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Give oxytocin</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Uterine massage</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Controlled cord traction</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Prostaglandin E1</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>All are the methods used for the removal of placenta, except Prostaglandin E1 as it is usually used in the induction of labor.</li>
<li>All other methods are used to remove the placenta in the third stage of labor.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 106</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Complementary feeding starts at: (PEDIA)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3 month</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>6 month</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>9 month</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>12 month</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The World Health Organization has recommended introducing solid foods along with breastfeeding at 6 months, while the American Academy of Allergy, Asthma and Immunology recommends starting solids between 4 and 6 months.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 107</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>India started COVID-19 vaccination with COVAXIN on:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>16 Jan 2021</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10 Jan 2021</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>16 March 2021</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>18 May 2021</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>India started COVID-19 vaccination with COVAXIN on 16th Jan 2021.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 108</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong>Identify the following image:</strong></p>
<p><img title="image044.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/3b716e17-4296-4c46-8133-b0ca32d25ea5.jpg" alt="" width="224" height="224" /></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>NG tube</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Child feeding tube</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>ET tube</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Suction tube</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The image is of an NG tube i.e. nasogastric tube which is used to deliver food and medicine through the nose to the stomach for the patient who are unable to meet their nutritional requirements due to the disease condition.</li>
<li>Child feeding tube is a general term that includes both nasogastric as well as abdominal tubes, hence we cannot select this answer.</li>
<li>ET tube is endotracheal tube and it looks like:</li>
</ul>
<p><img title="image045.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/985ca821-a97d-4216-bdfd-4761b0dfbce4.jpg" alt="" width="343" height="147" /></p>
<p><strong>Figure 1: ET Tube</strong></p>
<ul>
<li>Suction tubes are used for suctioning and it looks like:</li>
</ul>
<p><img title="image046.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/178f0368-83b7-48a3-9fc2-8609bb2c8619.jpg" alt="" width="225" height="225" /></p>
<p><strong>Figure 2: Suction Tube</strong></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 109</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong>Identify the following image:</strong></p>
<p><img title="image047.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/99b30c18-43a6-46e8-832a-9bc3c650948e.png" alt="" width="225" height="225" /></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Biohazard</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Radiation</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Cytotoxic</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>BMW</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>This symbol is of Biohazard which is used as a warning sign at places where the biological substance poses a threat to the health of living organisms, primarily humans.</li>
<li>The radiation symbol is used to aware the people that in a particular area harmful radiations are emitted so that they can avoid it. The symbol for radiation is:</li>
</ul>
<p><strong><img src="data:image/png;base64,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" /></strong></p>
<p><strong>Figure 1:</strong> Biohazard</p>
<ul>
<li>Cytotoxic is a substance that can cause cell damage or death. To make people aware of it, the symbol used is:</li>
</ul>
<p><img title="image050.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/ca05d97f-c343-46e5-89ee-46fb76a9ebeb.jpg" alt="" width="214" height="227" /></p>
<p><strong>Figure 2: Cytotoxic Hazard Symbol</strong></p>
<ul>
<li>Biomedical waste management (BMW) is the segregation and disposal of the hazardous waste generated during the diagnosis, treatment or immunization of human beings or animals or in research activities pertaining to or in the production or testing of biologicals. The symbol that represent BMW is:</li>
</ul>
<p><img title="image051.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/48bb2c3c-d223-40a6-be67-018d563b88ef.jpg" alt="" width="190" height="190" /></p>
<p><strong>Figure 3: Biomedical Waste Management</strong></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 110</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong>Identify the following image:</strong></p>
<p><strong><img src="data:image/png;base64,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" width="195" height="195" /></strong></p>
</body></html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Deaver retractor</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hohmann retractor</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Senn retractor</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ribbon retractor</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The image is of Deaver retractor which is used to hold back the abdominal wall during abdominal or thoracic procedures.</li>
<li><strong>Hohmann retractor</strong> used during orthopedic surgeries and can also be used to help in the bones manipulation.</li>
</ul>
<p><img title="image055.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/096b9d7f-fe18-4810-b2bb-0e542dcf7b2a.png" alt="" width="276" height="175" /></p>
<p><strong>Figure 1: Hohmann Retractor</strong></p>
<ul>
<li>Senn retractor is used to retract skin edges and deeper tissues of small incisions and it looks like:</li>
</ul>
<p><img title="image056.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/e64efd29-ffb5-4f20-8960-04173043841e.jpg" alt="" width="246" height="246" /></p>
<p><strong>Figure 2: Senn Retractor </strong></p>
<ul>
<li>Ribbon retractor is used&nbsp;to retract deep wounds and it looks like:</li>
</ul>
<p><img title="image057.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/1d080cc6-8789-4e94-83dc-a2111bd3b453.jpg" alt="" width="200" height="200" /></p>
<p><strong>Figure 3: Ribbon Retractor</strong></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 111</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Self-retainable catheter is: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Malecot catheter</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Rubber catheter</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Ryle&rsquo;s tube</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Robinson catheter</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Malecot catheter is a self-retainable catheter that is used to drain different body fluids like urine, pus or bile and it should not remain indwelling for more than four weeks.</li>
</ul>
<p><img title="image059.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/f3ef0225-63dc-44a8-abc2-ac9392751d14.jpg" alt="" width="248" height="248" /></p>
<p><strong>Figure: Malecot Catheter</strong></p>
<ul>
<li>Other options are incorrect as all those tubes are not self-retaining.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 112</h3>
                <p><b>A patient with blood transfusion has a light headache, chills and rashes. What nurse will expect to be ordered to the patient?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Adrenaline and noradrenaline</li><li>2. Atropine and adrenaline</li><li>3. Atropine and dexamethasone</li><li>4. Adrenaline and hydrocortisone</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Nurse expects an order of adrenaline and hydrocortisone. Adrenaline or Epinephrine causes stimulation of Î± adrenoceptors that increases peripheral vascular resistance. This will result in improving blood pressure and coronary perfusion which will help in reversing peripheral vasodilation and decreasing angioedema. On the other hand, hydrocortisone is administered when immediate effect of epinephrine/adrenaline does not occur.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 113</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A child reported in emergency with acute bronchospasm and has a history of Bee sting. What is the most preferred route of adrenaline administration?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Intraosseous</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Intramuscular</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Subcutaneous</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Intratracheal</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The most preferred route of adrenaline administration in all ages is through intramuscular route though its dose varies as:</li>
</ul>
<p><img title="image061.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/55abfaf1-950d-4511-9b9a-ad36cdca4c3f.jpg" alt="" width="357" height="292" /></p>
<ul>
<li>Other options are distractors.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 114</h3>
                <p><b>Difference between apical pulse and radial pulse is called:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Atrial flutter</li><li>2. Atrial fibrillation</li><li>3. Pulse deficit</li><li>4. Sinus bradycardia</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Difference between apical pulse and radial pulse is called Pulse deficit. It is checked when the pulse is very irregular. This is usually seen when the heart is too weak to produce a pulse and the heart beats fast to fill the blood.</li><li><b>Atrial flutter</b> is a condition when atria contracts at a higher rate, almost 300 bpm.</li><li><b>Atrial fibrillation</b> the rhythm of heartbeat is irregular.</li><li><b>Sinus bradycardia</b> is a type of slow heartbeat.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 115</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>What is chest compression and ventilation ratio in neonatal resuscitation?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3:1</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>4:1</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1:1</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1:2</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>Chest compression and ventilation ratio in neonatal resuscitation is 3:1. The chest compressions are coordinated with ventilations at a ratio of 3:1 and a rate of 120 events per minute in order to achieve approximately 90 compressions and 30 breaths per minute.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 116</h3>
                <p><b>All of the following are used in raised ICP, except: </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Mannitol</li><li>2. Hypoventilation</li><li>3. Hyperventilation</li><li>4. NS 5%</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>All of the following are used in raised ICP, except NS 5% because in raised ICP, Infusion of 75 mL hypertonic (10%) saline is preferred. It helps in decreasing the elevated ICP and increasing cerebral perfusion pressure in stroke patients in whom mannitol was ineffective.</li><li>Other options are incorrect as they all are used in the treatment of raised ICP.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 117</h3>
                <p><b>A 20 years man admitted in the hospital with massive hemorrhage due to RTA. Which cannula the nurse will use? </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 20G</li><li>2. 18G</li><li>3. 26G</li><li>4. 23G</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>18G cannula is used for massive blood transfusion because of a large bore that facilitates the flow of blood at a higher rate.</li><li>Other options are incorrect as their bore size is comparatively smaller than the 18G bore size.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 118</h3>
                <p><b>A female with scalded burn comes to the hospital. What is fluid of choice for initial stage fluid replacement?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. NS</li><li>2. RL</li><li>3. D5%</li><li>4. D10%</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Choice of fluid for initial stage of fluid replacement in burn is RL (Lactated ringer). Charles Baxter, is the most widely used fluid replacement formula for burn injuries. It specifies that 2 to 4 mL of Ringerâ€™s Lactate per kilogram of weight per percentage of body surface area burned, with the first half given over the first 8 hours and the remainder given over the next 16 hours. Its composition and osmolality closely resemble normal bodily physiological fluids and it also contains lactate which may buffer metabolic acidosis in the early post- burn phase.</li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 119</h3>
                <p><b>Which is not used for induction of labor with a history of previous LSCS?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Prostaglandin</li><li>2. Amniotomy</li><li>3. Oxytocin</li><li>4. Stripping of membranes</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Prostaglandin is not used for induction of labor with a history of previous LSCS as prostaglandin causes myometrial contraction and sensitizes myometrium to oxytocin and as a side effect it can lead to uterine tachysystole which may result in uterine rupture in a previous case of LSCS as the uterus is already scarred. </li><li>Other options are distractors.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 120</h3>
                <p><b>In which condition gastric lavage is contraindicated?</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Corrosive poisoning</li><li>2. Kerosene poisoning</li><li>3. Medication poisoning</li><li>4. None of the above</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>Gastric lavage is contraindicated in corrosive poisoning as if gastric lavage is done in this case, it can lead to the risk of esophageal perforation.</li><li>In all other cases, gastric lavage can be done to get rid of the poison.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 121</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A baby admitted in hospital with the complaint of foreign body aspiration. The nurse will do: </strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>5 back slap 5 chest thrust</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2 back slap 2 chest thrust</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Heimlich maneuver</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>CPR</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The nurse will do 5 back slap 5 chest thrust as:</li>
</ul>
<p><img title="image063.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/a8e1204d-652f-4741-a264-130d4b5da33d.jpg" alt="" width="371" height="280" /></p>
<p><strong>Figure: Management of Foreign Body Aspiration</strong></p>
<ul>
<li>Other options are distractors.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 122</h3>
                <p><b>Identify the correct method of inserting urinary catheter in a neonate:</b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 12 Fr is appropriate size for catheterization in neonate</li><li>2. No requirement of jelly</li><li>3. Inflate the balloon after insertion of entire catheter</li><li>4. Inflate the balloon when urine seen, no matter location of catheter</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>The correct method of inserting catheter in a neonate is that inflate the balloon when urine seen, no matter location of catheter because the flow of urine itself is an indication of correct placement of the urinary catheter. </li><li>5 Fr size urinary catheter is used for neonates and not 12 Fr.</li><li>Jelly is required and important while inserting catheter to prevent injuries.</li><li>The entire catheter is not inserted in a neonate; the catheter is inserted until the urine flow is seen.</li></ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 123</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>Weight of infant quadruples by:</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1 year</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2 years</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>3 years</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>4 years</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>Weight of infant quadruples by 2 years.</li>
<li>Other options are incorrect as:</li>
</ul>
<p><img title="image064.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/093a8c84-c645-4c62-bc36-ce26f0216470.png" alt="" width="310" height="208" /></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 124</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>A 50-year-old patient with 54% burn is admitted in the hospital. According to Wallace rule of 9, how many % is given to perineum?</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>1%</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>2%</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>4.5%</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>9%</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The perineum is given 1%. The rule of nines divides the BSA as:</li>
</ul>
<p><img title="image065.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/2650779b-ecac-4339-9245-e0ab7b78b08f.jpg" alt="" width="247" height="311" /></p>
<p><strong>Figure: </strong>Rule of Nines</p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 125</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong>Identify the image given below:</strong></p>
<p><img title="image067.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/3180a92a-0899-43a5-a372-bcce87d02260.jpg" alt="" width="224" height="117" /></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Bipolar cautery</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Monopolar cautery</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Electric pencil</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>None of the above</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The image given above is of a Bipolar cautery. It has 2 electrodes those are used to stop bleeding during procedure or after trauma through the provision of precise heat to the tissues.</li>
<li>Monopolar cautery looks like:</li>
</ul>
<p><img title="image068.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/acb2135c-a897-4c1e-9997-589e02614fad.jpg" alt="" width="225" height="225" /></p>
<p><strong>Figure: Monopolar Cautery</strong></p>
<ul>
<li>Electric pencil is another name for monopolar cautery.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 126</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong>Identify the image:</strong></p>
<p><img title="image070.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/26af5eca-bd3e-4ced-9598-1aea985ed6a7.jpg" alt="" width="222" height="136" /></p></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Penrose drain</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Hemovac drain</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>Jackson Pratt drain</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>None of the above</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The image is of Jackson Pratt drain and it has following parts:</li>
</ul>
<p><img title="image072.png" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/327af87f-b3d0-4d8c-a8e5-6f81e8a0f14a.png" alt="" width="339" height="339" /></p>
<p><strong>Figure 1: Jackson Pratt Drain</strong></p>
<ul>
<li>Jackson Pratt drain is used to help empty excessive fluid from the body after surgery.</li>
<li><strong>Penrose drain</strong> looks like:</li>
</ul>
<p><img title="image073.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/99678def-f680-412e-a7f9-762343359914.jpg" alt="" width="206" height="206" /></p>
<p><strong>Figure 2: Penrose Drain</strong></p>
<ul>
<li>Hemovac drain looks like:</li>
</ul>
<p><img title="image075.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/b452ea7b-093b-4593-9be4-2719f6ba7c58.jpg" alt="" width="224" height="225" /></p>
<p>&nbsp;</p>
<p><strong>Figure 3: Hemovac Drain</strong></p></li></ul></div></div>
            <div class="question">
                <h3>Question No: 127</h3>
                <p><!DOCTYPE html><html><head></head><body>
<p><strong>Identify the number of surgical blade:</strong></p>
<p><strong><img src="data:image/png;base64,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" /></strong></p>
</body></html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>11</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>15</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>20</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body>
<ul>
<li>The surgical blade is of 11 number.</li>
</ul>
<p>You can remember this through:</p>
<p><img title="image079.jpg" src="https://static.pw.live/5eb393ee95fab7468a79d189/ADMIN/3f3d628b-4a7f-47f9-9d1d-2df84973cf40.jpg" alt="" width="253" height="333" /></p>
<p><strong>Figure: BP Blades</strong></p>
<ul>
<li>Other options are distractors.</li>
</ul></li></ul></div></div>
            <div class="question">
                <h3>Question No: 128</h3>
                <p><b>Indiaâ€™s 1st indigenous COVID vaccine is: </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. Covaxin</li><li>2. Covishield</li><li>3. Moderna</li><li>4. Sputnik</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html><html><head></head><body><ul><li>India's 1<sup>st</sup> indigenous COVID vaccine is Covaxin.<ul style="list-style-type: circle;"><li><strong>Founder and manufacturer: </strong>Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) and Bharat Biotech</li><li><strong>Route: </strong>I/M</li><li><strong>Dose</strong>: 0.5 mL</li><li><strong>Site: </strong>Mid Deltoid</li><li><strong>2<sup>nd</sup> dose: </strong>(After 28 days or 4 - 6 weeks)</li><li><strong>Discarded after: </strong>6 hours of opening</li><li><strong>Stored at: </strong>2 - 8&deg;C</li><li>The vaccine received DCGI approval for Human Clinical Trials and the trials commenced across India from July, 2020.</li></ul></li><li>COVISHIELD vaccine:<ul style="list-style-type: circle;"><li><strong>Founder: Oxford University </strong>in collaboration with <strong>AstraZeneca</strong></li><li><strong>Manufactured by</strong>: <strong>Serum Institute </strong>in India</li><li><strong>Route: </strong>I/M</li><li><strong>Site: </strong>Mid Deltoid</li><li><strong>2<sup>nd</sup> dose: </strong>(Initially after 6 - 8 weeks i.e. 42 - 56 days, now after <strong>84 days or 12 - 16 weeks</strong>)</li><li><strong>Discarded after: </strong>6 hours of opening</li><li><strong>Stored at: </strong>2 - 8&deg;C</li><li><strong>Content: </strong>Adenovirus (Chimpanzee)</li></ul></li></ul><p>&nbsp;</p></body></html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 129</h3>
                <p><!DOCTYPE html>
<html>
<head>
</head>
<body>
<p><strong>The protection period provided by Cu-T 380 A is: (OBG)</strong></p>
</body>
</html></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>10 years</p>
</body>
</html></li><li>2. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>20 years</p>
</body>
</html></li><li>3. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>15 years</p>
</body>
</html></li><li>4. <!DOCTYPE html>
<html>
<head>
</head>
<body>
<p>5 years</p>
</body>
</html></li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><!DOCTYPE html>
<html>
<head>
</head>
<body>
<ul>
<li>The protection period provided by Cu-T 380 A is for 10 years. It is a T shaped device with a polyethylene frame holding 380 mm<sup>2</sup> of exposed surface area of copper. The frame of this IUD contains barium sulfate thus making it radio-opaque.</li>
<li>Other options are distractors.</li>
</ul>
</body>
</html></li></ul></div></div>
            <div class="question">
                <h3>Question No: 130</h3>
                <p><b>Normal urine output in an adult is: </b></p>
                <div class="options">
                    <h4>Options:</h4>
                    <ul>
            <li>1. 2500 mL</li><li>2. 3000 mL</li><li>3. 1500 mL</li><li>4. 500 mL</li></ul></div><div class="solution"><h4>Solution:</h4><ul><li><ul ><li>A healthy adult eliminates approx. 1,500 mL of urine every 24 hours.</li><li>The urinary bladder in adults has a normal capacity of between 300 and 500 mL. </li><li>Normal urine output is 1 - 2 mL/kg/hr. To determine the urine output of your patient, you need to know their weight, the amount of urine produced and the amount of time it took them to produce that urine.</li></ul></div></div>
        <div class="credits">
            <p class="rainbow-text">Credit: Code Written by BHASKAR</p>
        </div>
        </body></html>